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ABSTRACT 
 
Histatins, statherin and proline-rich proteins (PRPs) are important 
members of the human saliva proteome. They are components of the acquired 
enamel pellicle (AEP) which provides protection to the teeth and perform other 
vital functions in the oral cavity such as preventing spontaneous precipitation of 
calcium phosphate salts (statherin) and exhibiting fungicidal activity (histatins).  
The aims of the study were to (1) isolate histatins, statherin and acidic PRPs 
from parotid secretion, (2) develop a novel functional assay for the measurement 
of hydroxyapatite demineralization by modifying pre-existing methods and (3) test 
the binding of mixed PS proteins and purified salivary proteins (histatin 1, 
statherin and PRP1) to HA and the subsequent effect on demineralization.   
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The steps in the histatin, statherin and PRP purification process include 
zinc precipitation of parotid saliva, ion exchange chromatography, gel filtration 
chromatography and high performance liquid chromatography (HPLC). Protein 
purity was assessed by polyacrylamide gel electrophoresis (PAGE). The 
functional properties of the proteins were examined in two ways: Binding of 
mixed and purified proteins to ceramic hydroxyapatite (HA) powder was 
monitored by PAGE and HPLC,  and demineralization of HA exposed to acidic 
conditions after incubation with mixed and purified proteins was determined in 
spectrophotometric assays for free calcium and phosphate.  
Histatins and PRPs were successfully isolated to high levels of purity from 
human parotid saliva (HPS). Salivary protein binding experiments showed that 
the order of the three proteins studied in terms of their apparent affinity for HA is: 
statherin > histatin 1 > PRP1. The linearized Langmuir adsorption plots for 
histatin 1 and statherin fit well, showing R2 values of 0.9880 and 0.9975, 
respectively. However, the adsorption isotherm for PRP1 did not exhibit linear 
characteristics (R2 value of 0.61). Functional assays performed to measure the 
release of calcium and phosphate ions showed variable levels of protection 
afforded to HA by preincubation with the three proteins. On a molar basis, histatin 
1 provided the most protection against demineralization. The in vitro data 
generated add to a more complete understanding of the functional characteristics 
of histatins, statherin and PRP1 and thereby provide insights into their potential 
capacity to protect enamel in the oral environment.     
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1. Introduction 
 
1.1 Glandular Salivary Secretion 
 
Saliva, which is 99% aqueous by volume (Helmerhorst et al., 2004), is 
secreted in the oral cavity by three major salivary glands and various minor 
salivary glands. The three major salivary glands, the parotid, the submandibular 
and the sublingual glands, exist in pairs. The parotid glands contribute about 
50% of the total secretion when saliva flow is stimulated by mastication 
(Lendenmann et al., 2000). Whole saliva (WS) is primarily composed of glandular 
secretions. In addition it contains bacteria, leukocytes, sloughed epithelial cells 
and gingival crevicular fluid (GCF). GCF contributes markers to WS that are 
derived from the circulation. These markers make possible the diagnostic use of 
WS to detect HIV, periodontal disease, pancreatic cancer and acute myocardial 
infarction among other diseases (Thomadaki et al., 2011). Parotid and 
submandibular secretions are always supersaturated with respect to calcium and 
phosphate salts regardless of flow rate or diurnal variations. Calcium and 
phosphate are the major constituents of hydroxyapatite (HA) which makes up the 
structure of tooth enamel. This supersaturation of saliva with respect to these 
ions provides important protection for tooth surfaces. Except for the effects of 
dental caries, tooth enamel retains its integrity for many decades. Salivary 
supersaturation with respect to calcium and phosphate salts is responsible for 
this remarkable stability (Hay et al., 1979).  
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1.2 Functions 
 
Being a complex fluid, saliva has a variety of functions, most of which are 
protective and are important for the maintenance of healthy oral tissues. Saliva 
facilitates the swallowing of food, the remineralization of teeth, the general 
lubrication of the tissues in the oral cavity and the inhibition of the growth of 
microorganisms. It lubricates oral mucosal tissues which facilitates speech and 
swallowing and attenuates mechanical, thermal and chemical irritation. Saliva 
serves as an ion reservoir, facilitating remineralization of tooth enamel. It acts as 
a buffer, neutralizing plaque pH after food intake thus reducing demineralization 
which occurs below pH 5.5. It acts as an antimicrobial agent, helping to control 
the growth of the oral microflora. Agglutinins, which include mucins and 
glycoproteins, in saliva aggregate bacteria facilitating their clearance from the 
oral cavity. A protective pellicle, known as the acquired enamel pellicle, is formed 
on tooth surfaces from salivary proteins. The digestion of food starts in the oral 
cavity with the breakdown of starch by the salivary enzyme α-amylase. Secretory 
Immunoglobulin A, sIgA, may participate in both adaptive immunity via its Fab 
regions which are involved in specific antigen recognition and in innate immunity 
via its glycosylated regions (Helmerhorst and Oppenheim, 2007). sIgA also 
aggregates C. albicans (yeast) cells and facilitates their removal from the oral 
cavity by swallowing. Other innate host defense factors exhibiting anti-bacterial 
and antifungal activities include lactoferrin, lysozyme, salivary peroxidase and the 
histatins (Helmerhorst et al., 2004). Finally, saliva facilitates the sense of taste by 
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acting as a solvent, bringing food constituents into intimate contact with the taste 
buds. The crucial role of saliva is perhaps best illustrated by the symptoms 
accompanying xerostomia (dry mouth syndrome), which results in a rapid 
deterioration of oral health and a dramatic reduction in the quality of life of the 
sufferer (Edgar et al., 2004). 
 
1.3 Collection and Processing  
 
Saliva can be collected under stimulated or unstimulated conditions. 
Whole saliva is collected by directing a subject to expectorate into a collection 
tube. Unstimulated and stimulated parotid secretion is collected via a Curby Cup 
securely placed over the Stensen’s duct opening of the parotid glands. 
Stimulation is usually achieved by mastication of a parafilm bolus. The parotids 
are wedge shaped and are located in front of the ear and behind the ramus of the 
mandible. Submandibular/sublingual (SMSL) secretion is collected by means of 
an appliance (Truelove et al., 1967). The appliance fits over the SMSL glandular 
excretory ducts, also called Wharton’s ducts, which are located on the floor of the 
mouth. Parotid secretion is usually stimulated by sweet and sour candy. 
Glandular secretions flow freely through tubes attached to the respective 
appliances. The preservation of WS is a challenge due to the complexity of its 
composition and high proteolytic activity. Centrifugation to separate the 
supernatant from the pellet and freezing of the supernatant -20° C as soon as 
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possible after collection is the best way to preserve intact salivary proteins. 
Lowering or increasing the pH or boiling also have a preservative effect on WS. 
Cooling on ice at 0°C only ensures protein stability for up to one hour. Compared 
to the drawing of blood, saliva collection is relatively easy and stress-free, 
making its diagnostic use highly desirable (Thomadaki et al., 2011). 
 
1.4 Salivary Protein Separation 
 
Early studies aimed at the separation of salivary proteins used paper 
electrophoresis. However, polyacrylamide gel electrophoresis (PAGE) with a 
stacking gel soon became the standard due to the superior resolution of proteins 
achieved via this method (Mandel and Ellison, 1965). Anionic PAGE, developed 
by Ornstein (Ornstein, 1964) and Davis (Davis, 1964), provides excellent 
separation of proteins by molecular size and by net negative charge. It is 
uniquely suited for the separation and visualization of acidic proline-rich proteins 
and their isoforms. Cationic PAGE on the other hand provides excellent 
separation of positively charged proteins such as salivary histatins (Baum et al., 
1976, Oppenheim et al., 1986). Bis-Tris SDS PAGE is used to separate a broad 
range of proteins in their denatured state providing molecular weight 
determination since all proteins are rendered negative in charge by the addition 
of sodium dodecyl sulfate (Weber and Osborn, 1969). Larger amounts of protein 
can be separated by Fast Protein Liquid Chromatography (FPLC) or High 
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Performance Liquid Chromatography (HPLC). FPLC employs a number of 
different chromatographic techniques to achieve protein purification. These 
include size exclusion chromatography, also known as gel filtration, in which 
proteins are separated on the basis of their size, ion exchange chromatography, 
in which proteins are separated on the basis of their net charge and affinity 
chromatography which uses a stationary immobilized ligand that specifically 
binds the protein of interest. HPLC typically uses reverse phase / hydrophobic 
interaction columns that separate molecules on the basis of hydrophobic 
interactions between the sample and the stationary phase (Provost, 2012). HPLC 
with a GenPak FAX anion exchange column has been used to separate PRP 
isoforms and determine their concentrations in different glandular secretions 
(Hay et al., 1994).  
 
1.5 Components of Glandular Secretions 
 
The top five protein species in human saliva based on percentage of total 
protein are amylases, PRPs, cystatins, mucins and immunoglobulins. Statherin, 
carbonic anhydrase, histatins, lysozyme and serum albumin also have a 
significant presence.  Serum proteins including albumin, α-, β- and γ-globulin 
constitute <5% of total salivary protein (Ruhl, 2012). Amylase begins the 
digestion of food and is the strongest antigen in saliva. Lysozyme is thought to 
play an important role in the defense against gram-positive oral microorganisms. 
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In parotid secretion, about 35% of total proteins are bound to carbohydrates 
(Mandel and Ellison, 1965). Salivary agglutinin is a high-molecular-weight, acidic, 
mucinlike glycoproteins found in parotid and submandibular secretion. Its primary 
function is to aggregate bacteria which facilitates its clearance out of the oral 
cavity by swallowing (Lamont et al., 1991). Potentially harmful microbes are 
subsequently destroyed in the acidic gastric environment (Ruhl, 2012). 
Submaxillary, previously called submandibular, secretion contains about half the 
total protein found in PS under unstimulated conditions. It has a much lower level 
of amylase, higher lysozyme activity and contains cystatins. Cystatins are 
cysteine containing phosphoproteins which are found in saliva, cerebro-spinal 
fluid, seminal fluid, serum and tears (Lamkin et al., 1991). Submandibular 
secretion is more difficult to collect than PS because a custom fitted device is 
required. With this device, submandibular and sublingual secretions are collected 
together, and are referred to as SMSL secretion. Most submandibular salivary 
proteins are anionic rather than cationic and contain a distinct group of 
glycoproteins. About 75% of the population demonstrates blood group 
substances in SMSL secretion which are represented in the glycoprotein portion. 
SMSL contains more glycoproteins than PS secretion. The level of lipoproteins 
(lipids) in WS is very low. Both PS and SMSL secretion contain a number of free 
amino acids (Mandel and Ellison, 1965).  
Saliva contains serum-derived components resulting from passive 
diffusion via gingival crevices. Nitrite (NO2
-) and uric acid (UA) build up in the 
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serum of patients with end stage renal disease (ESRD). Solution based 
colormetric detection chemistries for these analytes have been converted to a 
test strip format. The test strips were developed to noninvasively monitor dialysis 
progress using a patient’s saliva. The net decreases in concentration observed 
for NO2
- and UA from predialysis to postdialysis support their potential utility as 
markers for dialysis efficacy (Blicharz et al., 2008).  
Low molecular weight salivary proteins include histatins, statherin and 
acidic, basic and glycosylated proline-rich proteins (PRPs). Acidic PRPs are 
found both in PS and SMSL and are rich in glycine, proline and glutamic acid 
(Kousvelari et al., 1982; Oppenheim et al., 1971). Cystatins and mucins are only 
present in SMSL secretion (Yao et al., 2003). Mucin and agglutinin are two of the 
largest proteins found in WS. Statherin and the acidic PRPs are especially 
important in maintaining the mineralization of tooth enamel.   
 
1.6 Acidic PRPs 
 
One of the unusual properties of human saliva is its high content of 
proline-rich proteins (PRPs). The acidic PRPs are effective inhibitors of crystal 
growth, but unlike statherin, do not inhibit spontaneous precipitation. There are 
six members of the acidic PRP family: three 150 residue proteins, PRP-1, PIF-s 
and PRP-2 and three 106 residue proteins, PRP-3, PIF-F and PRP-4 (Hay et al., 
1988). Tryptic digestion of PRPs 1 - 4 yields a single active N-terminal peptide 
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from each. The N-terminal region is strongly anionic with nearly half the residues 
being aspartate, glutamate and phosphoserine. The N-terminal regions of the six 
PRPs are nearly identical. The differences occur at residues 4 and 50: PRPs 1 
and 3 have Asp and Asn, PRPs 2 and 4 have Asp and Asp and PIF-s and PIF-f 
have Asn and Asp in those two positions, respectively (Hay et al., 1988). The 
mechanism behind crystal growth inhibition is thought to be adsorption of the 
inhibitory proteins onto the enamel surface where they block crystal growth sites 
and prevent mineral deposition (Hay et al., 1979). PRPs are divided into three 
groups: acidic, basic and glycosylated accounting, in total, for 10 - 40% of the 
total protein in human glandular secretion. Almost all of the phosphopeptides in 
WS arise from acidic PRPs. Other salivary proteins like statherin and cystatin are 
only a minor source of phosphoproteins (Minaguchi et al., 1988). PRPs provide a 
protective and reparative environment for tooth enamel and are selective 
mediators of bacterial adhesion to HA (Moreno and Zahradnik, 1979).  
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Fig. 1: The complete primary structure of PRP1 (Hay et al., 1988).    
 
Table 1: Summary of the structural differences in the six PRPs* 
 Position 4 Position 50 Total number of 
residues 
PRP1 Asp Asn 150 
PIF-s Asn Asp 150 
PRP2 Asp Asp 150 
PRP3 Asp Asn 106 
PIF-f Asn Asp 106 
PRP4 Asp Asp 106 
* Hay et al., 1988 
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In early studies, four acidic PRPs were isolated from parotid saliva (PS) 
that were not detected on gel patterns obtained from WS. The proteins were 
purified via gel filtration chromatography (G-75 column) and ion-exchange 
chromatography (DEAE-Sephadex A-25 Column). The purity of the fractions was 
confirmed by Ornstein-Davis disc gel electrophoresis. Amino acid analysis 
revealed the proteins to contain: 22 – 27% proline, 20 – 22% glycine and 26 – 
36% glutamate and aspartate. Sulfur containing amino acids and tyrosine were 
not found. The isoelectric points for the PRPs were between 4.09 and 4.71. The 
studies also indicated a high affinity for hydroxyapatite (Oppenheim et al., 1971). 
Phosphoserine is necessary for the maximal adsorption of acidic PRPs to 
hydroxyapatite (HA). Acidic PRPs account for 42% of all proteins adsorbed to HA 
in vitro. After digesting PRPs with phosphatase, ~60% of covalently bound 
phosphate was removed. Experiments showed decreased binding of protein to 
HA after treatment with phosphatase indicating that the phosphoserine residues 
are necessary for optimal binding (Bennick et al., 1979). The HA binding site is 
located in the protein’s N-terminal tryptic peptide. Trypsin digestions showed no 
change in the amount of valine or isoleucine (which are located in the N-terminal 
region) but a marked decrease in the amounts of other amino acids. These 
experiments showed that the C-terminal part was removed and that the N-
terminal peptide remained bound to HA (Bennick et al., 1979).  
 PRPs are encoded by two genes in the mammalian genome, designated 
PRH1 and PRH2. The PRH1 and PRH2 genes are closely related and differ by 
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only 8.7% (Azen et al., 1987). The primary products of the PRH1 gene are the 
proteins Db-s, PIF-s and Pa. The primary products of the PRH2 gene are PRP1 
and PRP-2. Db-f results from cleavage of Db-s between residues 127 and 128. 
Cleavage of PIF-s, PRP-1 and PRP-2 between residues 106 and 107 results in 
PIF-f, PRP-3 and PRP-4. Total PIF-s production is lower than total PRP-1 
production, indicating that the PRH2 gene has a higher rate of transcription than 
the PRH1 gene (Hay et al., 1994). Differences were found in the ability of PRP 
isoforms to inhibit calcium phosphate precipitation and to promote bacterial 
adhesion to HA. Bacteria were found to adhere much more strongly to PIF-s and 
PRP-1 than to the derivative peptides PIF-f and PRP-3. This is due to the 
presence of the pro-gln C-terminal dipeptide which is present in the 150 residue 
isoforms but absent in the truncated 106 residue PRPs. The relative production 
and post-translational cleavage of PRPs are constant in an individual’s parotid 
and submandibular saliva samples obtained over several weeks. However, 
substantial inter-gland differences and variation between individuals were 
apparent. These variations could be significant in the resulting biological activity 
of the PRPs. Variations in protein degradation between subjects are thought to 
be due to individual differences in the degree of proteolytic activity in the parotid 
glands or variations in the time saliva is retained in the duct system after 
secretion (Azen, 1973).  
The two protein pairs, PIF-s, PRP-1 and PIF-f, PRP-3 are difficult to 
separate by PAGE due to their identical charge. Anion exchange 
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chromatography using a very shallow chloride gradient was used to separate the 
PIF-s, PIF-f, PRP1 and PRP3 isoforms. The Asp - Asn substitution at position 4 
and not the Asn – Asp substitution in position 50 is thought to account for the 
separation of PIF-s and PRP1 due to steric differences. Pa dimer consists of two 
identical 150 amino acid peptides with a disulfide bond connecting two cysteine 
residues at position 103. Pa dimer is heavily retarded during anion exchange 
chromatography because of its two negatively charged N-terminal regions. PRP 
1 – 4 contain negatively charged Asp in position 4 and are also strongly retarded. 
Db-s, PIF-s, Pa, Db-f and PIF-f contain Asn in position 4 which results in a net 
charge that is less negative than PRP 1 – 4. Therefore they are the least 
retarded (Hay et al., 1994). Pa appears as a single band in IEF PAGE. However, 
the PRPs are partially cleaved at Arg 106 possibly by kallikrein in the salivary 
glands which results in a double-banded phenotype. One band of the pair 
represents intact PRP and the other band represents the larger of the cleaved 
fragments. Db-s and PIF-s refer to the uncleaved proteins while Db-f and PIF-f 
represent the larger of the cleavage products (Azen et al., 1987).  
 
1.7 Statherin 
 
Statherin is a 43 residue, tyrosine-rich acidic peptide with an isoelectric 
point of 4.2 and a molecular weight of 5380 Daltons. The complete amino acid 
sequence of statherin was determined by Edman degradation after digesting the 
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peptide separately with trypsin, chymotrypsin and Staphylococcus aureus 
protease. The resulting peptides were purified by gel filtration and the two serine 
residues at positions 2 and 3 were found to be phosphorylated. The 
supersaturation of saliva with respect to calcium salts is important for stabilizing, 
protecting and recalcifying enamel that has been demineralized by bacterial 
acids. Proteins (PRPs and statherin) in human saliva inhibit precipitation of 
supersaturated calcium phosphate solutions. Statherin is an unusually potent 
inhibitor of calcium phosphate precipitation and is regarded as a precursor of the 
acquired enamel pellicle (AEP) (Schlesinger and Hay, 1977). The probable 
mechanism for the inhibition of calcium phosphate precipitation involves the 
inhibitor (statherin) binding to newly formed aggregates of calcium and 
phosphate ions, thereby blocking their growth. At a concentration of 0.2 µM, 
statherin delays precipitation from a supersaturated solution for several hours. 
Statherin contains twelve charged amino acids, ten of which are located within 
the 13 N-terminal residues.  All of the tyrosine, proline and glutamine are found in 
the C-terminal two-thirds of the peptide, where they form 75% of the residues. 
The highly charged N-terminal ⅓ of statherin, which includes the phosphoserine 
residues, plays a particularly important role in binding the peptide to HA and in 
the subsequent inhibition of calcium phosphate precipitation. Removal of 
phosphate from the phosphoserines reduced activity to less than 2% of the 
activity of the phosphorylated tryptic fragment (Hay et al., 1979). Statherin has a 
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high degree of negative charge in its N-terminus and its hydrophobic C-terminus 
and hydrophilic N-terminus give it striking structural asymmetry.  
 
 
Fig. 2: The complete amino acid sequence of statherin (Schlesinger and Hay, 
1977). 
 
In a study by Tamaki and coworkers, the relationship between the 
concentration of salivary protein and the inhibition of calcium phosphate 
precipitation was found to be linear. Statherin was 14- and 66-fold more inhibitory 
than histatin-1 and WS respectively. Statherin was found to be the most potent 
salivary protein in inhibiting both primary and secondary precipitation of calcium 
phosphate while histatin-1 was the least inhibitory. Statherin and small PRPs 
adsorb to HA rapidly while large PRPs and histatins take considerably longer. 
Only statherin is considered to be an effective inhibitor of spontaneous 
precipitation at physiological concentrations (Tamaki et al., 2002). 
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Human statherin has been shown to inhibit primary (spontaneous) and 
secondary (seeded) precipitation of calcium phosphate salts. The highly 
negatively charged N-terminal region is important for the inhibition of both 
primary and secondary precipitation. The tyrosine-proline-glutamine rich C-
terminal region plays a critical role in the inhibition of primary precipitation. 
Maximal inhibition of primary precipitation requires the entire molecule. 
Molecules containing multiple anionic groups, ie. phosphate, are effective 
inhibitors of both types of precipitation. Digestion of statherin with 
caboxypeptidase-A removed approximately ten residues proximal to the C-
terminus and a large decrease in primary precipitation activity was observed in 
the truncated molecule (Schwartz et al., 1992). The biological function of 
statherin, concomitant with the PRPs is to inhibit potentially harmful calcium 
phosphate precipitation in the salivary glands and the mouth (primary 
precipitation) and onto tooth surfaces (secondary precipitation). Statherin levels 
in stimulated PS are more than sufficient to carry out its proposed function (Hay 
et al., 1984). However, it should be pointed out that the levels in WS are 
significantly diminished due to proteolytic fragmentation (Li et al., 2003, 
Helmerhorst et al., 2010). 
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1.8 Histatins 
Histatins 1, 3 and 5 are members of a histidine rich protein family found in 
human salivary secretion. Histatins are pellicle precursor proteins that have low 
molecular weight, have cationic characteristics, and exhibit antibacterial and 
antifungal properties. They inhibit the growth of certain oral bacteria such as 
streptococci and fungi such as C. albicans. Histatins sequestered on the enamel 
surface may form a reservoir that serves diverse functional roles including the 
killing of yeast and bacteria cells, inhibiting enzyme function and binding to other 
salivary components. Of all the histatins, only histatin 1 possesses an N-terminal 
phosphoserine residue which greatly increases its binding affinity for HA (Fig. 3) 
(Yin et al., 2003). 
While histatin 1’s single phosphoserine residue increases it’s affinity for HA 
compared to the non-phosphorylated histatin members, its overall affinity for HA 
is less than that of the PRPs or statherin. Histatin 5 has a relatively high positive 
charge due to the presence of seven histidine, three lysine and three arginine 
residues (Yin et al., 2006). The adsorption of a protein with low affinity for HA, ie. 
histatin 5, can be enhanced by binding to other proteins that are strongly bound 
to the enamel surface. Histatins kill various fungi, including C. albicans which is 
the most prevalent fungus in the oral cavity. C. albicans killing cannot be 
detected in PS, SMSL or WS. However, the fungicidal activity of PS is unmasked 
upon dialysis with MWCO ≥ 1000 Da tubing. Histatins were retained in samples 
dialyzed with 10,000 and 25,000 MWCO tubing even though their MW is <5000 
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Da. This is due to the fact that histatins, as well as statherin, form complexes with 
mucins (Iontcheva et al., 2000). Therefore, they can still be responsible for the 
antifungal activities in PS after dialysis.  
 
 
Fig. 3: Amino acid sequences of salivary histatins 1 – 5. Sp represents 
phosphoserine (Troxler et al., 1990). 
 
 
1.9 Hydroxyapatite (HA) 
 
HA, Ca
5
(PO
4
)
3
OH, is the least soluble calcium phosphate compound 
found in nature and in the body. Tooth enamel is impure HA with ions other than 
Ca2+ and (PO
4
)3- incorporated in the crystal lattice. Carbonate and fluoride are 
common impurities. The former makes HA more soluble and the presence of the 
latter results in a less soluble HA (Edgar et al., 2004). Each HA unit cell contains 
ten calcium ions, six phosphate groups and two hydroxyl groups, resulting in the 
formula: Ca
10
(PO
4
)
6
(OH)
2
. Two hydroxyl groups are stacked at z = ¼ and z = ¾ 
in each corner of the unit cell. Each hydroxyl group is surrounded by a triangle of 
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three Ca2+ ions. Each calcium triangle is rotated with respect to its partner 
triangle by 120°. Each calcium triangle is surrounded by triangles containing 
three phosphate (PO
4
)3- groups. The phosphate triangles are further surrounded 
by a ring of six calcium ions. The phosphate triangles act as a bridge between 
the inner Ca2+ triangles and the outer Ca2+ ring (Kay et al., 1964). The above 
described arrangement of ions occurs in each corner of the unit cell 
parallelogram. In an analysis of the interaction of salivary proteins with HA (Hay, 
1973), experiments using dental enamel powder and experiments using synthetic 
HA produced essentially similar results. Allowances were made due to variations 
in surface area. The smaller particle size and greater surface area of dental 
enamel powder may be due to the presence of impurities such as carbonate and 
fluoride in the unit cells. 
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Fig. 4: HA structure projected on an x,y plane (Kay et al., 1964).  
 
1.10 Acquired Enamel Pellicle (AEP) 
 
The AEP is a thin layer of organic material that forms on the enamel tooth 
surface. It’s functions include the inhibition of calcium phosphate crystallization, 
regulation of ion transport and a deterrent to microbial growth. Certain salivary 
proteins are regarded as pellicle precursors due to their affinity for HA. Amino 
acid analysis and Western blots of in vivo formed pellicle have shown the 
presence of many proteins including albumin, amylase, cystatins, PRPs, 
statherin, lysozyme and histatins. In addition to electrostatic interactions, protein 
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adsorption to enamel is often driven by an increase in entropy. The adsorption 
behavior of a single salivary protein can differ substantially from that obtained 
when that protein is part of a mixture of proteins (Yin et al., 2006). High-
resolution gel filtration chromatography experiments have revealed that small 
proteins and peptides with MW<10 kDa constitute approximately 30% of total 
AEP material (Siqueira and Oppenheim, 2009). 
The AEP covers the enamel and is not removed by tooth brushing and is 
only partially removed by prophylaxis. It consists of salivary proteins and lipids 
that form immediately when a freshly cleaned tooth surface contacts saliva. The 
pellicle protects the enamel from mechanical and chemical damage and delays 
the onset of caries and demineralization when the oral environment becomes 
acidic. Plaque is composed of bacteria in a polysaccharide matrix and forms a 
second layer between the tooth surface and the oral environment. The AEP 
retards the diffusion of acids formed in the dental plaque and regulates 
dissolution and precipitation processes. A trend towards greater plaque 
accumulation, expressed in terms of the number of Streptococcus mutans cells 
per unit surface area, on enamel surfaces with AEP was observed. Pellicle 
protection against demineralization, however, appears to be unrelated to the 
number of acid-producing bacteria present on tooth surfaces in vitro (Zahradnik 
et al., 1978).  
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1.11 Oral Bacteria and Acid Production 
 
Glycolysis is the central ATP-producing pathway used by anaerobic 
bacteria such as S. mutans which have a dominant presence in dental plaque. 
From one glucose molecule the following species are generated: two molecules 
of pyruvate, two molecules of ATP and two molecules of NADH. In anaerobic 
organisms, pyruvate is either converted into lactate or ethanol and CO
2
 by 
fermentation. NADH gives up it’s electrons and is converted back into NAD+ 
which is required to maintain the reactions of glycolysis (Alberts et al., 2008). 
Excreted lactate acquires a proton in the weakly acidic oral environment and 
reaches the following equilibrium (Zumdahl and Zumdahl, 2006): 
CH
3
CH(OH)COOH(aq) ↔ H
+ (aq) + CH3CH(OH)COO
-
(aq)  
(where CH
3
CH(OH)COOH is lactic acid and  CH
3
CH(OH)COO
-
 is lactate).  
The oral environment is ideal for bacterial growth due to its humidity, 
temperature, large surface area for attachment and the presence of nutrients. A 
proper amount of saliva, with its anti-microbial agents, is necessary to maintain a 
balance between host defense and microbial attack. S. mutans and lactobacilli 
are commonly present in the oral cavity and are known as lactic acid producers 
because they convert lactose and other sugars into lactic acid. The Stephan 
Curve (Fig. 5) shows the change in plaque pH in response to an oral rinse with a 
glucose solution. The lactic acid producing bacteria in the plaque rapidly 
metabolize sugar to lactic acid by fermentation which accounts for the initial dip 
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in the curve. The rise in plaque pH is due to the diffusion of acids out of the 
plaque and into the saliva. The presence of acid neutralizing ammonia in saliva is 
due to the breakdown of urea and free amino acids.  
 
 
Fig. 5: Stephan Curve showing the changes in plaque pH over time following a 
sucrose rinse, (Edgar et al., 2004). 
 
 
1.12 Proteomics 
 In a recent study, three research groups worked in concert to produce a 
catalog of the human salivary proteome with maximal coverage (Denny et al., 
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2008). The objective was to improve coverage of the salivary proteome and 
access low-copy proteins using mass spectrometric methods. The research 
teams produced 11592 distinct peptide sequences that matched 2153 protein 
accession numbers. 57% of the proteins were shared between PS and SMSL. 
Well known salivary proteins such as α-amylase, cystatin, histatin, PRPs and 
mucins were well represented in the core proteome. The molecular weight 
distribution of the proteins in the core proteome is as follows: 46.6% ≤ 40 kDa, 
44.6% 40 – 120 kDa and 8.7% ≥ 120 kDa. As of 2012, the proteome of human 
saliva has been essentially completed (Ruhl, 2012).  
Human saliva is desirable for use as a diagnostic fluid due to its 
advantages compared to other body fluids such as blood or urine. Interest in 
saliva as a diagnostic fluid has increased recently along with advancements in 
proteomic analysis including surface enhanced laser desorption/ionization time-
of-flight mass spectrometry (SELDI-TOF-MS), a high throughput, sensitive 
technique which has revealed a large number of components that are present in 
low concentrations and could serve as biomarkers for disease. SELDI-TOF-MS 
studies on WS show most peaks in the low molecular weight (MW) range 
indicating an abundance of peptides between 1-6 kDa. A comparison of SELDI-
TOF-MS spectra reveals that a majority of WS protein originate in the parotid 
gland. However, high molecular weight proteins and glycoproteins such as 
mucins were not detected by this method (Schipper et al., 2007).  
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Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-
MS) has also been a valuable tool for the cataloguing of bacterial proteomes, the 
identification of differences in protein expression in diseased vs. normal cells and 
the characterization of post-translational protein modification. Proteins found in 
AEP and WS were identified for the first time using MS (Yao et al., 2003). 2-D 
PAGE using isoelectric focusing with pH ranges of 3 – 10 and 5 – 8 in the 
horizontal dimension and SDS-PAGE (10%) in the vertical dimension was used 
to compare proteins in WS and AEP and PS and SMSL. Significant differences in 
the protein patterns for glandular secretions and WS were observed. The 
electrophoretogram for WS contains many more protein spots than in PS or 
SMSL. The WS spots are also distributed more evenly throughout the pH range 
5-8. This indicates that WS contains a mixture of proteins both derived from 
different sources and having undergone significant modification upon entering 
the oral cavity.  
2-DE allows for the separation of not only different molecules with similar masses 
by also different isoforms of the same molecule. MS allows for the positive 
identification of proteins and peptides. Calgranulin and cytokeratin family 
members were identified as novel AEP constituents (Yao et al., 2003).  These 
proteins were identified by MS and are derived from non-salivary glandular 
sources. Calgranulin B was identified in WS and AEP. Advances in proteomics 
have increased the number of proteins identified and raised the level of 
sophistication and sensitivity of the analysis of biological materials.  
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Enzymatic fragmentation of proteins and peptides having MW > 5000 Da 
is required prior to MS analysis due to the limitations of the instrument. In an 
investigation of the human AEP proteome, 78 peptides originating from 29 
different proteins with a MW range of 767 – 3981 Da were identified via liquid 
chromatography electrospray ionization tandem mass spectrometry (LC-ESI-
MS/MS) without prior proteolytic treatment (Siqueira and Oppenheim, 2009). By 
avoiding enzymatic fragmentation (trypsination), information on naturally 
occurring salivary peptides in the AEP can be obtained (Siqueira et al., 2007). 
 
1.13 Langmuir Adsorption Equation 
 The Langmuir equation relates the adsorption of molecules on a solid 
surface to the concentration of the molecules in a medium above the surface at a 
constant temperature. It is used to describe the following adsorption equilibrium:  
 
where S represents empty surface binding sites, P represents protein molecules 
in solution and SP represents occupied binding sites (Milan et al., 2006). The 
Langmuir isotherm is based on three assumptions: 1) Adsorption cannot proceed 
beyond monolayer coverage, 2) All sites are equivalent and the surface is 
uniform and 3) The ability of a molecule to adsorb at a given site is independent 
of the occupation of neighboring sites (Atkins et al., 2002).   
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 The Langmuir adsorption equation is used in this study to analyze the 
adsorption of salivary proteins to HA. The experimental adsorption data should 
satisfy the following equation: 
 
where Q is the moles of protein adsorbed per unit surface area (m2) of HA, C is 
the equilibrium concentration (mol/L) of protein remaining in solution after 
equilibration, N is the maximum number of binding sites available to the protein 
(per unit surface area) and K is the equilibrium constant which reflects the affinity 
of an adsorbate for an adsorbent or, in this case, the affinity of the protein for HA. 
This equation can be rewritten in the form of a linear equation (  
 
where  is the slope of the linear plot of  vs C and  is the y-axis intercept. 
From the slope and y-axis intercept, the values of K and N can be obtained. If the 
data fit reasonably well to the Langmuir model, the resulting adsorption isotherms 
are characterized by a steep increase followed by a leveling off which indicates 
saturation of the available binding sites on the surface. In the linearized 
adsorption plot, a correlation coefficient ≥ 0.9 and a positive y-axis intercept are 
required for the data to demonstrate Langmuir type adsorption (Milan et al., 
2006).  
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2. Aims of the Study 
 
1) To isolate histatins, statherin and acidic PRPs from parotid secretion. 
2) To develop a novel functional assay for the measurement of hydroxyapatite 
demineralization by modifying pre-existing methods.  
3) To test the binding of mixed PS proteins and purified salivary proteins (histatin 
1, statherin and PRP1) to HA and the subsequent effect on demineralization.    
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3. Materials and Methods 
 All studies involving human subjects were approved by the Institutional 
Review Board at Boston University (protocol # H-23046, P.I. Dr. Frank G. 
Oppenheim). 
 
3.1. Parotid Saliva Collection  
 
 PS was collected from healthy volunteers via a Curby Cup positioned over 
the orifice of the Stensen’s duct in the oral cavity. The Curby Cup was securely 
positioned and sealed by negative pressure to avoid contamination with WS. PS 
flow was stimulated by use of the gustatory method employing Life Savers or 
similar candy. PS was collected in 50 ml conical tubes which were kept on ice.   
 
3.2. Zinc Precipitation of PS to obtain Histatins and Statherin 
 
 The PS samples (total volume approximately 300 ml) were pooled in a 
beaker placed in a bucket containing crushed ice. For 80 ml of HPS, 5.5 ml of 10 
mM ZnCl2 and 350 µl 2M NaOH solution was added for a final ZnCl2 
concentration of 650 µM and a solution pH of 9.0). After raising the pH the 
sample solution became cloudy. After incubation on ice for one hour, the 
suspension was transferred to centrifuge tubes to collect the precipitate. The 
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tubes were balanced and centrifuged using an RC-6+ Centrifuge (Thermo Fisher, 
Waltham, MA, USA) and SS-34 Rotor (Sorvall / Kendro, Newtown, CT, USA) for 
20 min at 20,000 RPM and 4º C. The supernatant was carefully removed from 
each tube using a serological pipet, pooled in a beaker, covered with aluminum 
foil and placed in a refrigerator for no more than one hour while preparing for 
dialysis (see Section 3.3.). The PS supernatant contains the proline rich proteins 
(PRPs) and the zinc pellet contains histatins and statherin (Flora et al., 2001). 
  
3.3. PS Supernatant Dialysis and Lyophilization 
 1000 Da MWCO Dialysis Membrane Tubes (Spectrum Labs, Rancho 
Dominquez, CA) were used to dialyze the PS supernatant obtained after zinc 
precipitation. The membrane was rinsed three times before adding the 
supernatant, not exceeding 150 ml per membrane section. The filled membranes 
were sealed with tubing clips and placed in a large bucket containing 12 liters of 
cold, deionized (DI) water and a magnetic stirrer. The bucket was placed on a stir 
plate in the cold room. The bucket was observed to make certain that the stir bar 
was moving but not hitting the membranes. Dialysis was performed in three four 
hour cycles. The DI water in the bucket was changed after the first and second 
cycle. After dialysis, the membrane contents were transferred to lyophilization 
flasks, shell frozen and lyophilized. The desalted, lyophilized PS supernatant 
protein devoid of statherin and histatins was transferred to a labeled bottle and 
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stored in a -20º C. Freezer. See SOP: “Virtis FM25EL Lyophilizer, serial # 
217622”, for more information on lyophilizer methodology (Appendix 6.1). 
     
3.4. DEAE anion-exchange chromatography 
A portion of the PS supernatant proteins was weighed out and dissolved in 
DEAE anion-exchange buffer A (50 mM TrisHCl, 50 mM NaCl, pH 8.0) to a final 
concentration of approximately 10 mg/ml. The solution was centrifuged for 20 
min. at approximately 30,000 g using a SS-34 Rotor and the RC-6+ Centrifuge 
(ThermoFisher). The supernatant was removed using a pipet and the small pellet 
comprising insoluble minor protein components was discarded.   
 Aliquots of 25 ml containing 250 mg protein were applied to a DEAE 
Sepharose anion exchange column (40 X 2.6 cm, column volume = 186 ml) 
using the AKTA FPLC System (GE Healthcare, Piscataway, NJ). Before starting 
the actual run, buffer A was allowed to flow through the column for one hour to 
ensure UV baseline stability. The flow rate was 1.0 ml/min. The buffers used for 
anion exchange chromatography were: Buffer A: 50 mM TrisHCl, 50 mM NaCl, 
pH 8.0; Buffer B: 50 mM TrisHCl, 1 M NaCl, pH 8.0. The following gradient was 
used: 100% buffer A for 465 ml, ramp to 100% buffer B in 93 ml, 100% buffer B 
for 233 ml and step to 100% buffer A for 279 ml.  
 The first DEAE peak, which contained the void proteins, eluted between 
60 and 250 ml. The fractions from several runs of the same starting solution were 
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combined in a flask and lyophilized. The lyophilized sample was dissolved in 
water, transferred to a 50 ml conical tube (labeled “VOID”) and stored in a -20º C. 
Freezer. The second DEAE peak, eluting between 8.2% and 35% Buffer B or 
480 and 550 ml, from several runs was also combined and lyophilized. The 
lyophilized sample was dissolved in water, transferred to a 50 ml Conical Tube 
(labeled “DEAE”) and stored in a -20º freezer.   
 
3.5. Gel filtration chromatography 
 Proteins in the samples labeled “Void” and “DEAE” were desalted on the 
G-25 Column using the Pharmacia FPLC system (Pharmacia, Uppsala, 
Sweden). Prior to this, the DEAE column was disconnected and sealed. The G-
25 Column (100 X 2.6 cm) was connected and equilibrated with water and 25 ml 
sample aliquots were subsequently applied. They were run through the G-25 
column using DI water as the mobile phase. The first peak, eluting between 170 - 
230 ml, contained the acidic PRPs and was transferred to a flask and lyophilized. 
The lyophilized sample was fluffy in appearance and transferred to a 50 ml 
conical tube labeled “DEAE for MONO Q Column”. 
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3.6 Mono Q anion-exchange chromatography  
 Lyophilized DEAE protein desalted with the G-25 column was dissolved in 
Buffer A (50 mM TrisHCl, 50 mM NaCl, pH 8.0) to produce a solution with a 
concentration of 10 mg/ml. The solution was centrifuged for 15 min at 20,000 
RPM (31,210 g) and the small pellet was discarded. The supernatant was 
transferred in 5 ml aliquots to 15 ml conical tubes labeled “DEAE for MONO Q”. 
The aliquots were run sequentially on the MONO Q HR 16/10 column (CV = 20 
ml) in conjunction with an AKTA FPLC. Samples were eluted at 1.0 ml/min using 
the following gradient: hold at 0% buffer B for 100 ml, ramp from 0% to 14% 
buffer B in 100 ml, ramp from 14% to 15.5% buffer B in 800 ml, ramp from 15.5% 
to 22% buffer B in 180 ml and ramp from 22% to 100% buffer B in 40 ml. Buffer B 
consists of 50 mM TrisHCl, 1 M NaCl, pH 8.0. The resulting chromatogram 
showed at least eight peaks. Each peak contained one or more PRP proteins. 
Peaks 1 – 8 were transferred into separate lyophilization flasks and lyophilized. 
The lyophilized samples were dissolved separately in DI water and transferred to 
labeled 50 ml conical tubes and stored in a -20º C freezer. After Mono Q 
chromatography the samples were desalted by elution through the G-25 
Sephadex Medium gel filtration column as indicated above. The first peak 
(containing the PRPs) was collected and lyophilized. The resulting lyophilized 
protein samples were light and fluffy. They were transferred to labeled tubes and 
stored at -20º C. See the SOP: “Pharmacia FPLC” and “FPLC AKTA PURIFIER 
10” for more information (Appendix 6.2). 
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3.7. PAGE Technical Aspects 
 The proteins isolated by zinc precipitation and DEAE/gel filtration 
chromatography were investigated for purity using cationic and anionic PAGE. 
Prior to pouring a gel, the gaskets were placed in a beaker of water to soak. The 
glass plates were washed prior to use (short plates and 1.5 mm spacer plates). 
The short plates were marked at the level to which the separating gel solution 
should be added (1.0 cm below the comb). The glass plates were placed in the 
casting stand. Water was added between the glass plates and a timer was set a 
timer for 20 min. After 20 min. the glass plates were checked for leakage. The 
separating gel solution was degassed by aspiration and a 10 ml serological pipet 
was used to add it to the space between the glass plates. The separating gel was 
overlaid with a layer of butanol about 5 mm in height. The separating gel was 
allowed to polymerize for 45 min.  
 After 45 minutes the butanol was removed, the gel was rinsed with DI 
water and blotted dry. The stacking gel solution was added on top of the 
separating gel. A comb was inserted and a lamp was placed in front of the gel. 
Light catalyzes polymerization of the stacking gel which takes about 30 min to 
polymerize. While the stacking gel was polymerizing, the sample to be loaded on 
the gel was prepared. After 30 min had expired, the light was turned off. The 
comb was carefully removed and the gels were transferred to a gel box. The 
appropriate running buffer was added to the middle chamber of the gel box to the 
top of the glass plates and were checked for leakage after 10 min. If there was 
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any leakage, the glass plates were removed, checked and put back in the gel 
box, making sure they were properly sealed against the rubber gaskets. The 
space in the gel box outside of the glass plates was filled with running buffer to 
one inch above the bottom of the glass plates. The samples were loaded with a 
gel loading pipette. The maximum volume loaded per lane was 40 µl. The lid was 
placed on the gel box which was connected to a power supply. A constant 
voltage of 120 V was applied. Electrophoresis took approximately 1.5 hours 
using the BioRad Mini Protean II with a BioRad Power Supply (Bio-Rad 
Laboratories, Hercules, CA).  
 
3.8. Cationic PAGE 
 Cationic PAGE was conducted as described previously (Baum et al., 
1976; Oppenheim et al., 1986). This type of electrophoresis provides excellent 
separation of histatins in their native state, based on their positive charge and 
size. 
 The concentration of the ingredients in the separating gel solution, 
pH=2.74, are as follows: 14.6% acrylamide, 0.78% bis-acrylamide, 0.125 M KOH, 
8.0 mM TEMED, 1.64 mM ammonium persulfate, 13 µM riboflavin 5-phosphate, 
4.4 M acetic acid. 
 The concentration of the ingredients in the stacking gel solution, pH=5.9, 
are as follows: 2.5% acrylamide ,0.625% bis-acrylamide, 60 mM KOH, 8.3 mM 
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TEMED, 19.4 µM riboflavin 5-phosphate and 0.584 M sucrose. The cationic 
PAGE sample buffer (1X) contains 1.17 M sucrose and 1.22 mM methyl green. 
The upper (anode) running buffer (1X) contains 0.37 M glycine. The pH is 
adjusted to 4.0 with glacial acetic acid. The lower cathode running buffer (1X) 
contains 0.72 M glacial acetic acid. The pH was adjusted to 4.3 with 45% KOH.  
 
3.9. Ornstein / Davis Polyacrylamide Gel Electrophoresis (Anionic PAGE)  
 The method for anionic PAGE is based on two articles (Ornstein, 1964 
and Davis, 1964) and is summarized in a doctoral dissertation (Oppenheim, 
1973). Anionic PAGE electrophoresis provides excellent separation of proteins 
by molecular weight and by negative charge. It is uniquely suited for the 
separation and visualization of acidic proline-rich proteins.  
 The concentrations of the ingredients in the separating gel solution, pH = 
8.9, are as follows: 375 mM Tris Base, 1.917 mM TEMED, 7.3% acrylamide, 
0.195% bis-acrylamide, 3.067 mM ammonium persulfate. The concentrations of 
the ingredients in the stacking gel solution, pH = 6.7, are as follows: 83 mM Tris 
Base 2.56 mM TEMED, 3.33% acrylamide, 0.833% bis-acrylamide, 8.86 µM 
riboflavin, 779 mM sucrose.The concentrations of the ingredients in the sample 
buffer are: 60 mM Tris base, 7.7 mM TEMED, 0.56 M sucrose, 12 mM 
bromphenol blue. The concentrations of the ingredients in the running buffer, pH 
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= 8.3, are as follows (10X solution): 0.25 M Tris Base, 1.92 M glycine. The 
solution was diluted 1:10 with DI water before use. 
 
3.10. Hydroxyapatite (HA) binding assay 
 Aliquots of 1.0 mg HA powder (Bio-Rad Macro-Prep Ceramic HA Type I 
40 µm) were weighed into fifteen 1.5 ml centrifuge tubes.  To the HA samples 1.0 
ml of histatin 1, statherin or PRP1 solutions were added, the concentrations are 
indicated in Table 1. Each concentration indicated was added to the HA powder 
in triplicate. Samples were incubated in an orbital hybridization incubator mixer 
for one hour. The samples were removed from the incubator and centrifuged at 
21,130 x g for 1 min (Eppendorf Centrifuge model 5424). A 0.75 ml aliquot of the 
supernatant was removed without disturbing the pellet at the bottom of the tube 
and transferred to another tube. From this aliquot, 75 ul was subjected to RP-
HPLC (see Section 3.11). 
 
3.11 Reversed-phase high performance liquid chromatography (RP-HPLC) 
 RP-HPLC analysis was performed using a HPLC Model 715 (Gilson, 
Middleton, WI) with a C-18 column (TSK-GEL 5 µm, ODS-120T, 4.6 mm X 250 
mm, TOSOHaas, Montgomeryville, PA). Samples in the Histatin 1, Statherin and 
PRP1 experiments were eluted using a linear gradient from 0 to 55% buffer B 
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(80% acetonitrile, 0.1% trifluoroacetic acid) over a 74 min. time interval at a flow 
rate of 1.0 ml/min. Buffer A was acidified DI water (0.1% trifluoroacetic acid). The 
eluate was monitored at 219 nm. This was done to determine C, the amount of 
protein remaining in the supernatant after incubation with HA.  
 
3.12 HA demineralization assay 
The pellet obtained after the protein adsorption assay (Section 3.10) was 
washed two times with water. To each pellet 1 ml of lactic acid (10 mM) was 
added, the samples were incubated for 30 min. in the rotating incubator at room 
temperature and centrifuged. After centrifugation, the supernatant was removed 
and diluted for the Calcium and Phosphate Assays, 1:10 and 1:40 respectively.    
 
 
Table 2: Summary of Histatin 1 binding and demineralization experiments. 
First incubation, 1 hr. @ 37º C with HA Second Incubation, 30 min. @ room 
temp. 
DI water 10 mM Lactic Acid 
20 µM histatin 1 solution 10 mM Lactic Acid 
50 µM histatin 1 solution 10 mM Lactic Acid 
100 µM histatin 1 solution 10 mM Lactic Acid 
200 µM histatin 1 solution 10 mM Lactic Acid 
DI water DI water 
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Table 3: Summary of Statherin binding and demineralization experiments. 
First incubation, 1 hr. @ 37º C with HA Second Incubation, 30 min. @ room 
temp. 
50 mM NH4HCO3 10 mM Lactic Acid  
25 µM statherin solution 10 mM Lactic Acid 
50 µM statherin solution 10 mM Lactic Acid 
100 µM statherin solution 10 mM Lactic Acid 
50 mM NH4HCO3 50 mM NH4HCO3 
25 µM statherin solution – no HA  
50 µM statherin solution – no HA  
100 µM statherin solution – no HA  
 
Table 4: Summary of PRP1 binding and demineralization experiments. 
First incubation, 1 hr. @ 37º C with HA Second Incubation, 30 min. @ room 
temp. 
DI water 10 mM Lactic Acid 
25 µM PRP1 solution 10 mM Lactic Acid 
50 µM PRP1 solution 10 mM Lactic Acid 
100 µM PRP1 solution 10 mM Lactic Acid 
DI water DI water 
25 µM PRP1 solution – no HA  
50 µM PRP1 solution – no HA  
100 µM PRP1 solution – no HA  
 
 
3.13. Assay to measure free calcium (Ca2+)  
 Free calcium in the lactic acid treated HA samples was measured using 
orthocresolphthalein complexone (OCPC) (Connerty and Briggs, 1966).  Two 25 
µl aliquots of each standard and diluted supernatant were transferred to a 96 well 
plate followed by the addition of 250 µl OCPC Reagent. The OCPC Reagent 
consisted of: 4.5% (v/v) aminoethanol , 1.4 % (v/v) ethanol , 29 mM Boric Acid, 
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0.25 mM KOH, 43 mM Acetic Acid, 5 mM 8-Quinolinol and 62 mM o-
cresolphthalein complexone. The Ca standards contained 0, 0.24, 0.5, 0.7, 1.0 or 
1.2 mM Ca respectively using a CaCO3 solution. 
 The OCPC Reagent absorption maximum is approximately 350 nm. After 
complexation with Ca2+ the absorbance maximum shifts to 560 nm. The 
absorbance was measured at 560 nm against a reagent blank and the Ca 
standards. The absorbance was measured using the Genios plate reader 
(Tecan, Research Triangle Park, NC, USA). Before measuring the absorbance, 
the 96 well plate was covered with sealing tape and incubated at 37º C for 30 
minutes. All glassware was rinsed with DI water and 0.5 N HCl to remove any 
traces of calcium and baked in the oven until completely dry. Pyrex glass-
stoppered volumetric flasks were used. 
 .  
3.14. Assay to measure free phosphate (PO4)3- 
 Free phosphate in the lactic acid treated HA samples was measured using 
an established method for the determination of inorganic free phosphate (Work, 
1981). Two 86 µl aliquots of each standard and diluted supernatant were 
transferred to a 96 well plate followed by 200 µl reaction solution. The phosphate 
reaction solution was 0.86 N sulfuric acid, 81 mM ascorbic acid and 2.9 mM 
ammonium molybdate. The phosphate standards contained 0.03, 0.08, 0.17, 
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0.25 and 0.3 mM phosphate respectively and were prepared using a Na2HPO4 
stock solution.  
 The phosphate reaction solution’s absorption maximum is approximately 
250 nm. After complexation with phosphate the absorbance maximum shifts to 
825 nm. The absorbance was measured at 825 nm against a reagent blank and 
the phosphate standards. The absorbance was measured using the Genios plate 
reader (Tecan, Research Triangle Park, NC, USA). Before measuring the 
absorbance, the 96 well plate was covered with sealing tape and incubated at 
37º C for 30 minutes.    
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4. RESULTS 
4.1 Histatin and Statherin Isolation 
 
  The first goal was to isolate histatins and statherin from human parotid 
secretion (PS).  PS from several donors was incubated with zinc chloride under 
basic conditions to precipitate histatins and statherin.  The precipitate was 
subsequently dissolved in 2% TFA, and aliquots were subjected to reversed 
phase HPLC.  This yielded four major peaks representing, in order of elution, 
histatin 5, 3, 1, and statherin (Flora et al., 2001). The individual peaks were 
collected and dried. Cationic PAGE was used to assess the purity of the histatins 
(Fig. 6A).  As a reference, whole PS protein was analyzed on the same gel (lane 
8). The darkest bands in the PS sample corresponded to histatins 1, 3 and 5. 
The isolated histatins were relatively pure but contained some impurities which 
reflect other, minor histatins. The histatin 1 preparation likely contained traces of 
histatin 2, the histatin 3 preparation likely contained traces of histatin 4, and the 
histatin 5 preparation traces of histatin 6.  The histatin 3 sample (lane 5) 
appeared to be of the highest purity.  The histatins shown in Fig. 6A were further 
purified by isocratic elution using RP-HPLC.  The histatin 1 shown in Fig. 6B, 
lane 1, representing the phosphorylated histatin family member, was used in the 
binding and functional assays described in sections 3.10 and 3.12.   
  The purity of the statherin preparation was evaluated by anionic PAGE 
(results not shown). The statherin preparation that was used for in the binding 
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and functional assays described in sections 3.10 and 3.12 was isolated by Dr. 
Traboulsi, and the purity of this preparation has been reported earlier (Traboulsi 
et al., 2010). 
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Figure 6A: Cationic PAGE of proteins in zinc-precipitated pellet from PS.  Lane 
1: Histatins 1, 3 and 5 (mixed standards), 19 µg total; Lane 2: Histatin 5 
(synthetic), 3 µg; Lane 3: empty; Lane 4: Histatin 1, 20 µg; Lane 5: Histatin 3, 20 
µg, Lane 6; Histatin 5, 20 µg; Lane 7: empty; Lane 8: HPS, 200 µg.   
Figure 6B: Cationic PAGE of histatins purified from zinc-precipitated PS pellet by 
RP-HPLC (isocratic elution). Lane 1: Histatin 1, 20 µg, Lane 2: Histatin 1, 3 and 5 
(standards), 20 µg. The gels were stained with Brilliant Blue. 
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4.2 Acidic PRP Isolation 
 
The PRPs were purified from the desalted and lyophilized PS supernatant 
devoid of histatins and statherin. DEAE anion exchange chromatography was 
used to separate the cationic proteins appearing in the void volume eluting 
between 75 and 275 ml from the anionic PRPs, eluting between 480 and 550 ml. 
Figure 7 shows the sample separation between the two peaks with the beginning 
of PRP elution and the increase in conductivity caused by an increase in the 
percentage of buffer B occurring simultaneously. After DEAE chromatography, 
the fraction containing the PRPs was desalted by G-25 gel filtration 
chromatography. The elution pattern, presented in Fig. 8 showed two major 
peaks, one eluting between 160 – 230 ml and one eluting between 350 and 450 
ml. The fractions from the first peak were collected and lyophilized. The mixture 
of PRPs in the lyophilized material were then dissolved in buffer A (50 mM Tris 
HCl, 50 mM NaCl) and applied to a Mono Q Column (Fig. 9). The Proteins were 
eluted using a shallow gradient (14% to 15.5% buffer B in 40 CV). Each peak in 
the Mono Q chromatogram represents a different PRP isoform. The level of 
purity of the proteins in each of the Mono Q Peaks was evaluated by anionic 
PAGE (Fig. 10). The position of the individual PRPs is indicated in the margin of 
the gel and is known from previous studies conducted in our lab as well as 
published studies. The PRP 1, PRP 2 and Pa Dimer were relatively pure. 
However, the other PRP isoforms appeared to contain various amounts of 
impurities and may require further purification. The PRP1 preparation (lane 5) 
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was used in the binding and functional assays described in sections 3.10 and 
3.12. 
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Figure 7: Anion Exchange Chromatography using a 40 cm DEAE Sepharose 
Column to separate the PRP Proteins (DEAE Peak) from the Void proteins. The 
black rectangles correspond to the fractions that were collected and pooled. The 
amount loaded was 250 mg. 
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Figure 8: Gel Filtration (Size Exclusion) Chromatography of DEAE Peak using a 
100 cm Column containing Sephadex G25 Medium.  The black rectangle 
indicates the fractions containing PRP proteins that were pooled and collected. 
Mixed PRP solution (pooled from multiple DEAE anion exchange runs) was 
loaded in 25 ml aliquots. 
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Figure 9: Anion Exchange Chromatography using a Mono Q HR 16 Column to 
separate individual PRP Proteins. The black rectangles correspond to the 
fractions that were pooled from each peak (P1 – P8). The amount of protein 
applied to the column was 30 mg. 
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Figure 10: Anionic PAGE of Mono Q peaks 1-8. The individual peaks obtained 
from anion exchange chromatography (Fig. 9) were subjected to anionic PAGE. 
Lane 1: PS 200 µg; Lane 2: Peak 1 (PIF-s) 20 µg; Lane 3: Peak 2 (Db-f) 20 µg, 
Lane 4: Peak 3 (PIF-f) 20 µg; Lane 5: Peak 4 (PRP1) 20 µg; Lane 6: Peak 5 
(PRP2) 20 µg; Lane 7: Peak 6 (PRP3) 20 µg; Lane 8: Peak 7 (PRP4) 20 µg; 
Lane 9: Peak 8 (Pa Dimer) 20 µg. The gel was stained with Amido Black. The 
bands are identified based on previous anionic PAGE experiments carried out in 
the lab of Dr. Frank Oppenheim at BUGSDM (Helmerhorst and Oppenheim, 
2007) and elsewhere (Zakhary et al., 2007). 
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4.3. Binding and Demineralization Experiments with PS and HA 
 
 Different amounts of HA (1.0, 2.0, 4.0, 6.0, 8.0 and 10.0 mg) were 
incubated for 15 min with lyophilized parotid saliva protein solutions (2.0 mg/ml). 
After various time intervals, the suspensions were centrifuged and 100 ul aliquots 
of the supernatant were loaded on the gel to assess PS protein binding to HA. 
Anionic PAGE (Fig. 11) clearly showed that as the amount of HA that was 
incubated with PS increased, (lanes 4 – 9) less and less protein was detectable 
in the supernatant and no PRPs were visible after incubation with >6.0 mg HA. 
Based on this result, it is reasonable to assume that all of the binding sites in 1.0 
mg HA are occupied after incubation with 1.0 ml PS solution (2.0 mg/ml).   
 In the next experiment 1.0 mg of HA was incubated with PS protein 
solutions (1.0, 1.5, 2.0, 3.0, 4.0 and 5.0 mg/ml). After the supernatant was 
removed, the HA was incubated with 1.0 mM lactic acid. The released calcium 
was determined using the OCPC assay (see section 3.13), and the mM calcium 
released was established by comparison to a standard curve. The results 
presented in Fig. 12 indicate that approximately the same amount of calcium was 
released from HA regardless of preincubation with PS protein. Therefore, calcium 
release from HA by lactic acid could not be prevented by preincubation of HA 
with PS protein.      
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Figure 11: Anionic PAGE of PS before and after incubation with different 
amounts of HA. Lanes 1 and 2: PS protein, 200 µg/lane. Lanes 4-9: PS protein 
solution (2 mg/ml) was incubated with increasing amounts of HA (1.0, 2.0, 4.0, 
6.0, 8.0 and 10.0 mg respectively), 100 ul/lane. The supernatants were applied to 
lanes 4 – 9. The gel was stained with Amido Black.   
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Figure 12: Calcium release assay. An aliquot of 1.0 mg HA was incubated with 
the indicated concentrations of PS for one hour before being treated with 1.0 mM 
lactic acid (pH 3.5). The supernatants were subsequently assayed for free 
calcium.    
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4.4 Binding Experiments with Pure Proteins and HA  
4.4.1. Histatin 1 binding to HA 
 
 To study the binding of histatin 1, HA was incubated with isocratically 
purified histatin 1 solutions or with water (Table 2) and the supernatants were 
analyzed by Bis-Tris Gels (Fig. 13) and by HPLC (Fig. 14). The gels and HPLC 
results both show positive binding of His 1 to HA. In Fig. 13, the bands in Gel #1, 
lanes 2 – 5 (stock solutions) are noticeably more prominent than the bands in Gel 
#1 lanes 6 – 9 and in Gel #2 lanes 2 – 5 and 6 – 9 which correspond to the 
histatin 1 solutions after incubation with HA. In Fig. 14, the peaks in 
Chromatogram B, which correspond to the histatin 1 solutions after incubation 
with HA are 40 – 50% lower than the peaks in chromatogram A which 
correspond to the histatin 1 solutions not incubated with HA. Both of these results 
indicated that histatin 1 bound to HA. Fig. 15 is a graphical representation of the 
results obtained in the HPLC experiment (Fig. 14). After incubation with HA, the 
2, 4, 8 and 16 nmol histatin 1 solutions were depleted of protein by 76%, 67%, 
53% and 39% respectively with respect to the stock solutions.   
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Figure 13: 12% Bis-Tris PAGE of histatin 1 solutions before and after incubation 
with HA. Lane 1: molecular weight standards; lanes 2 – 5: histatin 1 stock 
solutions (200, 100, 50 and 20 µM respectively); lanes 6 – 9: histatin 1 stock 
solutions (200, 100, 50 and 20 µM respectively) after incubation with HA.   
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Figure 14: RP-HPLC Chromatograms (UV 219 nm) of histatin 1 incubated 
without and with hydroxyapatite. 1 ml aliquots of four different histatin 1 solutions 
(200, 100, 50 and 25 µM) were incubated without or with 1 mg HA. After 1 hr 
incubation at 37º C, samples were centrifuged and 75 µl aliquots of the 
supernatant, containing the indicated amounts of histatin 1, were analyzed by 
RP-HPLC. A) Histatin 1 stock solutions, B) Histatin 1 stock solutions after 
incubation with HA.  
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Figure 15: Peak heights of His 1 in HPLC experiment presented in Fig. 14. The 
blue line corresponds to the peak heights in Figure 14A and the red line 
corresponds to the peak heights in Figure 14B.  
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4.4.2. Statherin binding to HA 
To study the protective effects of statherin, HA was incubated with pure 
statherin solutions or with ammonium bicarbonate solution (ABS) before being 
treated with 10 µM lactic acid (Table 3). The supernatants obtained after the first 
incubation were analyzed by RP-HPLC to assess binding of statherin to HA. In 
this experiment, a control was included to assess the stability of statherin during 
the 1h incubation at 37º C.  Chromatogram A (Fig. 16A) shows the statherin 
peaks of the stock solutions which had been stored at -20º C (control solutions). 
Chromatogram B (Fig. 16B) shows the stock solutions incubated for 1h at 37ºC 
without HA and chromatogram C (Fig. 16C) shows the corresponding peaks from 
the stock solutions after incubation with HA. The results indicated that incubation 
alone did not cause degradation of statherin (Figure 16B). The presence of HA 
substantially removed statherin from the solution (Figure 16C). Fig. 17 is a 
graphical representation of the statherin peak heights obtained in the HPLC 
experiment. After incubation with HA, the 2, 4 and 8 nmol statherin solutions 
were depleted of protein by 96%, 77% and 49% respectively with respect to the 
stock solutions.   
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Figure 16: RP-HPLC Chromatograms (UV 219 nm) of statherin incubated 
without and with hydroxyapatite. 1 ml aliquots of three different statherin 
solutions (100, 50 and 25 µM) in 50 mM NH4HCO3 were incubated without or 
with 1 mg hydroxyapatite. After 1 hr incubation at 37º C, samples were 
centrifuged and 75 µl aliquots of the supernatant, containing the indicated 
amounts of statherin, were analyzed by RP-HPLC. A) Statherin stock solutions 
(untreated, control), B) Statherin stock solutions incubated without HA, C) 
Statherin stock solutions after incubation with HA.  
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Figure 17: A chart showing the statherin peak heights (results of the HPLC 
experiment in Fig. 16). The blue line corresponds to the peaks in Fig. 16A and 
the green line corresponds to the peaks in Fig. 16C. The red line corresponds to 
statherin stock solutions incubated without HA (Fig. 16B).   
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4.4.3. PRP1 Binding to HA 
 
 To study the protective effects of PRP1, HA was incubated with different 
concentrations of PRP1 solutions (Table 4). After protein binding, the suspension 
was centrifuged and the amount of protein in the supernatant was measured by 
RP-HPLC (Fig. 18).  Chromatogram A (Fig. 18A) shows the PRP1 peaks of the 
stock solutions which were stored at -20º C (control solutions). Chromatogram B 
(Fig. 18B) shows the PRP1 peaks from the stock solutions incubated at 37º C 
without HA and Chromatogram C (Fig. 18C) shows the PRP1 peaks from the 
stock solutions after incubation with HA. Fig. 19 is a graphical representation of 
the peak height results obtained in the RP-HPLC experiment. After incubation 
with HA, the 2, 4 and 8 nmol PRP1 solutions were depleted of protein by 20%, 
7% and 6% respectively with respect to the stock solutions. This contrasts with 
the corresponding values obtained for statherin which were 96%, 77% and 49%.   
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Figure 18: RP-HPLC Chromatograms (UV 219 nm) of PRP1 incubated without 
and with hydroxyapatite. 1 ml aliquots of three different PRP1 solutions (100, 50 
and 25 µM) in water were incubated without or with 1 mg HA. After 1 hr 
incubation at 37º C, samples were centrifuged and 75 µl aliquots of the 
supernatant, containing the indicated amounts of PRP1, were analyzed by RP-
HPLC. A) PRP1 stock solutions (untreated, control), B) PRP1 stock solutions 
incubated without HA, C) PRP1 stock solutions after incubation with HA.  
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Figure 19: A chart showing the PRP1 binding results of the HPLC experiment in 
Fig. 18. The blue line corresponds to the peaks in Fig. 18A (control), the red line 
corresponds to the peaks in Fig. 18B and the green line corresponds to the 
peaks in Fig. 18C.   
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4.5 Analysis of the Histatin 1, statherin and PRP1 binding in Langmuir plots 
The Langmuir adsorption equation was used in this study to analyze the 
adsorption of pure histatin 1, statherin and PRP1 to HA. The average peak 
heights from the HPLC binding experiments are given in Table 5. The total 
amount of protein in the stock solutions, S, was reflected by the peak heights of 
the stock solutions incubated without HA. The amount of protein remaining in 
solution after incubation with HA, C, was reflected by the peak heights of the 
stock solutions after incubation with HA. Finally, Q, the amount of protein 
adsorbed per unit surface area of HA, is determined by subtracting C from S. The 
values for S, C and Q are given in Table 6. C and Q values were subsequently 
used to obtain the Langmuir linear plots and adsorption isotherms for histatin 1, 
statherin and PRP1. The HPLC chromatograms for histatin 1, statherin and 
PRP1 are shown in Figures 14, 16 and 18 respectively. As a control, aliquots of 
the statherin and PRP1 stock solutions were analyzed by HPLC without 
incubation. The difference between the incubated and unincubated stock 
solutions was not significant.   
The histatin 1 and statherin adsorption isotherms (Figs. 20B and 21B) 
were characterized by a steep increase followed by a leveling off which indicates 
saturation of the available binding sites on the surface. Based on the 
characteristics in the linear plot, the values for N and Ka were determined (Table 
7). The values of N, the number of binding sites and Ka, the binding affinity 
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constant, were not calculated for PRP1 because the R2 value obtained from the 
plot of the linearized data was too low (0.78). Indeed, PRP1 did not show typical 
adsorption characteristics (Figure 22). The two variants of the constant K are Kd, 
the dissociation constant with units of molarity (mol/L) and Ka, the association 
constant which is defined as Ka = 1/Kd. Ka has units of L/mol. A greater value of 
Ka indicates greater affinity of the ligand (protein) for the substrate (HA). 
According to the data presented in Table 7, the difference between histatin 1 and 
statherin in terms of the number of binding sites (N) is not significant. However, 
the Ka of statherin is an order of magnitude higher than that of histatin 1. This 
indicates that statherin has a much greater affinity for HA than histatin 1.     
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Table 5: HPLC Peak heights (mV) from Histatin 1, Statherin and PRP1 Binding 
Experiments. A linear relationship between the average peak heights and protein 
concentration is assumed. 
Protein 
Solution 
nmol present 
in 75 µl 
Avg. peak 
height (mV)*   
SD Avg. peak height 
(mV), after 
incubation with HA  
SD 
Histatin 1 1.5 0.64 0.050 0.16 0.015 
3.75 1.76 0.049 0.58 0.075 
7.5 4.17 0.026 1.96 0.047 
15 8.47 0.761 5.18 0.265 
Statherin 1.875 0.73 0.123 0.04 0.029 
3.75 1.61 0.194 0.38 0.024 
7.5 2.89 0.137 1.52 0.168 
PRP1 1.875 3.40 0.102 2.72 0.231 
3.75 6.52 0.481 6.10 0.096 
7.5 14.27 0.433 13.36 0.090 
*Peak heights less background  
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Table 6: The variables C and Q for the Langmuir plots determined from the 
HPLC peak heights (see Table 5).  
Protein 
Solution 
Total 
conc. 
(µM)  
 
nmol 
present 
in 1 ml 
Conc. in 
supernatant (C) 
after incubation 
with HA (µM) 
nmol protein 
bound to 1 
mg HA* 
Protein 
bound per 
unit surface 
area (Q, 
µmol/m2) 
Histatin 
1 
 
20 20 5.0 15.0 0.375 
50 50 16.4 33.5 0.838 
100 100 47.0 53.0 1.325 
200 200 122.3 77.7 1.943 
Statheri
n 
 
25 25 1.37 23.63 0.591 
50 50 11.8 38.2 0.955 
100 100 52.6 47.4 1.185 
PRP1 25 25 20 5 0.125 
50 50 46.8 3.2 0.80 
100 100 93.6 6.4 0.160 
* 1 mg HA has a surface area of 0.04 m2 
 
Table 7: N and K values determined from the linear Langmuir plots 
 Number of Binding 
Sites (N) µmol/m2 
Binding Affinity 
Constant (Ka) l/µmol 
Correlation 
Coefficient (R2) 
Histatin 1 2.40 0.0323 0.99 (n=4) 
Statherin 1.23 0.425 0.99 (n=3) 
PRP1 * * 0.61 (n=3) 
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Fig. 20: Langmuir Plots of Histatin 1 adsorption onto HA. A is the linear plot and 
B is the calculated adsorption isotherm (see Section 1.13).   
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Fig. 21: Langmuir Plots of statherin adsorption onto HA. A is the linear plot and B 
is the calculated adsorption isotherm (see Section 1.13).   
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Fig. 22: Langmuir Plots of PRP1 adsorption onto HA. A is the linear plot and B is 
the calculated adsorption isotherm (see Section 1.13).   
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4.6. Demineralization assay results 
4.6.1. Histatin 1 protection against demineralization 
  After the histatin 1 solutions were incubated with HA, the supernatant was 
removed. The HA was rinsed with water and incubated with 10 mM lactic acid 
solution (Table 2). The supernatants were removed and tested for free calcium 
and phosphate by colorimetric assays. The standard curves for the calcium and 
phosphate assays are given in Figure 23. The results of the calcium and 
phosphate release assays from histatin 1-coated HA are given in Fig. 24. Both 
assays indicate a trend towards greater protection against calcium or phosphate 
release with increasing histatin 1 concentration. However, the trend is somewhat 
understated and is more apparent in the calcium assay.  
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Figure 23: Representative standard curves for the detection of calcium and 
phosphate ions in solution. A) Calcium standards from dissolved CaCO
3
, and B) 
Phosphate standards from dissolved Na
2
HPO
4
. Indicated are the concentrations 
of the free Ca
++
 and (PO
4
)
3- ions.   
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Figure 24: Assays for calcium and phosphate released from HA after incubation 
with histatin 1: A) Calcium Release Assay, B) Phosphate Release Assay. HA, 
incubated with water or with different concentrations of His1, was treated with 10 
mM Lactic Acid. HA = Hydroxyapatite, DIW = Deionized Water, LA = 10 mM 
Lactic Acid. Calcium and phosphate released were determined by comparison to 
the standard curves shown in Figure 23. 
0.01 
6 6.3 
7.65 7.93 
8.45 
0
1
2
3
4
5
6
7
8
9
DIW / DIW 200 µM His 1
LA
100 µM His 1
LA
50 µM His 1
LA
20 µM His 1
LA
DIW / LA
C
a
2
+
 C
o
n
c
e
n
tr
a
ti
o
n
 (
m
M
) 
A 
0.03 
3.61 3.42 
4.14 4.09 
4.48 
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
DIW / DIW 200 µM His 1
LA
100 µM His 1
LA
50 µM His 1
LA
20 µM His 1
LA
DIW / LA
P
h
o
s
p
h
a
te
 C
o
n
c
e
n
tr
a
ti
o
n
 (
m
M
) B 
73 
 
4.6.2. Statherin protection against demineralization 
 As with histatin 1, colorimetric assays were performed on the 
supernatants from the second incubation (Table 3) to determine the amount of 
calcium and phosphate released from statherin coated HA after incubation with 
lactic acid (Fig. 25). Both assays indicate a trend towards greater protection 
against calcium or phosphate release with increasing statherin concentration. 
However, it is unlikely that the differences are statistically significant. 
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Figure 25: Assays for calcium and phosphate released from HA after incubation 
with statherin solutions or ammonium bicarbonate solutions: A) Calcium Release 
Assay, B) Phosphate Release Assay. Concentrations were determined by 
reference to standard curves similar to those shown in Figure 23. 
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4.6.3. PRP 1 protection against demineralization 
For PRP1, colorimetric assays were performed on the supernatants from 
the second incubation (Table 4) to determine the amount of calcium and 
phosphate released from HA after incubation with lactic acid (Fig. 26). The trend 
towards some protection against calcium and phosphate release with increasing 
protein concentration that was observed with histatin 1 and statherin was not 
seen with PRP1. The level of calcium and phosphate released was about the 
same for all the samples that were treated with lactic acid.   
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Figure 26: Assays for calcium and phosphate released from HA. HA incubated 
with water or different PRP1 solutions was treated with 10 mM Lactic Acid (LA). 
A) Calcium Release Assay, B) Phosphate Release Assay.  Concentrations were 
determined by reference to standard curves similar to those shown in Figure 23.  
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4.6.4. The effect of extended incubation times on PRP1 binding and 
protection of HA.  
 
The final experiment attempted to determine the effect of longer 
incubation times of the PRP1 solution with HA on the amount of protein bound to 
HA after incubation. The supernatants collected after four incubation times were 
analyzed by HPLC (Fig. 27). Fig. 28 is a histogram of the average peak heights 
from Fig. 27 and the two other sample series (not shown). There was a 12% 
depletion of PRP1 after the first hour of incubation, 16% depletion after 8 hours 
and 15% after 24 hrs, indicating the maximum amount adsorbed was reached 
within 1 h incubation. The PRP1 depleted from the supernatants is assumed to 
have bound to HA. In addition, calcium and phosphate assays were performed 
on the supernatants obtained after HA incubation (Fig. 29). For this experiment, 
samples incubated for 24 hours were used. The calcium and phosphate release 
data confirm that the protection achieved after pre-incubation with PRP1 is 
minimal. 
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Figure 27: The binding of PRP1 to HA after different incubation times. The 
amount of PRP1 after incubations of 1, 4, 8 and 24 hours in the supernatant was 
assessed by quantitative RP-HPLC using a C-18 column. Protein quantitation 
was derived from the average peak heights from triplicate experiments. 
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Figure 28: PRP1 peak heights after various incubation times with HA. The 
results of an HPLC experiment to determine whether the amount of PRP1 bound 
to HA increases as the incubation time with HA increases. The number of hours 
on the x-axis indicates the incubation time of the PRP1 stock solution with HA.  
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Figure 29: Assays for calcium and phosphate release.  HA, incubated with 50 
µM PRP1 solution or water, was treated with 10 mM lactic acid (LA) for 30 min. 
A) Calcium Release Assay, B) Phosphate Release Assay.   
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5. DISCUSSION  
 
The goal of the present investigation was to isolate and purify salivary 
proteins and to evaluate the effect of selected proteins on tooth enamel 
protection in functional assays. Histatins were successfully isolated from parotid 
saliva (PS) by zinc precipitation and RP-HPLC. The histatin 1 sample, which 
contained traces of histatin 2, was used in subsequent demineralization 
experiments. The acidic PRPs were purified from desalted and lyophilized PS 
supernatant obtained after zinc precipitation to remove histatins and statherin. 
They were purified via column chromatography in three steps: low resolution 
anion exchange, gel filtration and high resolution anion exchange using a Mono 
Q Column. The separation of the individual acidic PRP isoforms was achieved in 
the final step. The peak containing PRP1 (Peak 4 in Fig. 9 and Lane 5 in Fig. 10) 
had good resolution and a high level of purity. This isoform was chosen for use in 
the subsequent binding and demineralization experiments. The statherin that was 
used in these experiments had been previously purified and isolated in our 
laboratory (Helmerhorst et al., 2011). 
 In the past, various chromatographic approaches have been used to 
isolate histatins, statherin and acidic PRPs. In a method described by 
Oppenheim and coworkers (Oppenheim et al., 1986), histatins were isolated in 
three steps: 1) fractionation of PS protein on a DEAE-Sephadex A-25 ion 
exchange chromatography column equilibrated with 50 mM Tris-HCl and 25 mM 
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NaCl, pH 8.0 using a linear NaCl gradient (0.025 – 1.5 M), 2) desalting of the 
histatin-rich fractions on a Bio-Gel P-2 column and chromatography on a CM Bio-
Gel A column equilibrated with 25 mM sodium acetate and 25 mM NaCl, pH 5.0 
using a linear NaCl gradient (25 – 800 mM ), 3) final purification by gel filtration 
on a Bio-Gel P-6 column equilibrated and developed with 50 mM ammonium 
bicarbonate, pH 8.0. CM Bio-Gel A is a cation exchange resin which is necessary 
to separate histatins and statherin which elute from the DEAE-Sephadex A-25 
Column together. The eluate was monitored at 230 nm which is the wavelength 
of absorbance for a peptide bond. A method for the preparation of highly purified 
statherin was reported (Schlesinger and Hay, 1977). This method includes 
fractionation of PS on a DEAE Sephadex ion exchange column, gel filtration 
using Bio-Gel P-6 and anion exchange chromatography using Bio-Rad DEAE-
agarose with a NaCl gradient. Flora and coworkers in 2001 first discovered the 
precipitation of histatins with zinc under alkaline conditions. The method was 
further optimized (Helmerhorst et al., 2011) and is now the first step in the 
isolation of histatins and statherin in our and other laboratories.    
 A procedure for PRP isolation from human parotid secretion was 
described first by Oppenheim and coworkers (1971). The method that resulted in 
the purification of the four major salivary acidic proteins (PRP 1 – 4) included the 
following steps: 1) isolation of the protein components of interest by ammonium 
sulfate fractionation, 2) gel filtration on a Sephadex G-75 Column, 3) low 
resolution ion exchange chromatography on DEAE-Sephadex A-25 using a steep 
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NaCl gradient, 4) final purification on DEAE-Sephadex A-25 using a shallow 
NaCl gradient and 5) Disc gel electrophoresis to monitor the purity of the proteins 
(PRP 1 – 4). Another article (Bennick, 1975) described a modified approach: 1) 
Gel filtration on a Sephadex G-50 Column, 2) purification by cation-exchange 
chromatography on CM-cellulose CM-32, 3) further purification by anion 
exchange chromatography on DEAE-Sephadex A-25 and 4) desalting on a 
Sephadex G-25 Column. Bennick used this procedure to purify a single salivary 
phosphoprotein, Protein A, which corresponded to PRP-3 that had been isolated 
by Oppenheim and coworkers in 1971. Its primary structure is identical to the first 
106 residues of acidic PRP-1. In recent years, we have optimized PRP isolation 
in our laboratory. The current approach minimizes the use of column 
chromatography in order to reduce protein loss, particularly in ion exchange 
chromatography. The starting material used is PS protein that had been depleted 
of histatins and statherin by the zinc precipitation procedure. The initial desalting 
is accomplished via dialysis. The cation exchange chromatography step is 
unnecessary because histatins (and statherin) were already removed. Using two 
chromatography steps, low resolution (DEAE Sepharose) and high resolution 
(Mono Q) anion exchange chromatography, the major acidic PRP isoforms are 
purified.  
 After the proteins were obtained in adequate quantities at a sufficient level 
of purity, functional assays could be performed. Four experiments were carried 
out to study the binding of salivary protein (histatin 1, statherin and acidic PRP1) 
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to hydroxyapatite (HA). In a qualitative experiment, the binding of mixed proteins 
from parotid saliva to HA was investigated by anionic PAGE (Fig. 11). The data 
showed that as the HA amount increased PRPs were depleted from the PS. 
Subsequent binding experiments were carried out with purified proteins. HPLC 
was used to quantitatively assess the binding of histatin 1, statherin and PRP1 to 
HA. The results of these experiments show that statherin exhibits the highest 
affinity for HA followed by histatin 1 and PRP1 (Table 8). In partial agreement 
with these findings, statherin has been shown to be a much stronger inhibitor of 
seeded calcium phosphate precipitation than either histatin 1 or PRP1 (Tamaki, 
et al., 2002). 
Table 8: Percentage of protein bound to HA after incubation with the indicated 
pure salivary protein (from Figs. 14, 16 & 18).   
 2 nmol protein 4 nmol protein 8 nmol protein 
Histatin 1 76% 67%           53% 
Statherin 96% 77% 49% 
PRP1 20% 7% 6% 
 
 
It is logical to assume that statherin, which has two N-terminal 
phosphoserine residues, has greater affinity for HA than histatin 1 which has only 
one phosphoserine. The negatively charged phosphoserines bind via favorable 
electrostatic interaction to the Ca2+ ions in the HA crystal lattice. The extra 
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phosphoserine is largely responsible for statherin’s lower PI (4.2) compared to 
that of histatin 1 (7.0). In a comparative study (Hay, 1973), statherin, followed by 
histatin 1, were shown to exhibit the highest affinity for HA among all salivary 
proteins. Hay’s finding was the result of examinations of the proteins adsorbed to 
5, 20 and 50 mg of HA from 10 ml samples of PS. With 5 mg of HA, the only 
component to be significantly adsorbed was statherin, indicating its high affinity. 
With 20 mg of HA, adsorption of both statherin and histatin 1 was observed. 
PRPs only adsorbed at the 50 mg level, indicating their lower affinity for HA. It is 
noted in the study that statherin and histatin (which were referred to at the time 
as Components I and II) each contain about 25% acidic amino acid residues 
whereas PRPs contain about 36%. However, a major cause of the reduced 
affinity for HA by PRPs is that a significant percentage of its acidic residues (Asp 
and Glu) are present in the amidated form (Asn and Gln), as determined by free 
amine titration after hydrolysis (Oppenheim, 1973). Amidation increases the 
overall IEP of the protein, making its binding to HA less favorable.  
In this study, functional assays were performed to measure the release of 
calcium ion and phosphate. In the three experiments carried out with histatin 1, 
statherin and PRP1, the protection provided to HA by protein binding was 
variable (Table 9). The trend towards protection against demineralization was 
most pronounced for histatin 1 where a 29% decrease in free calcium between 
the supernatant from unprotected HA and the supernatant from HA pre-incubated 
with 200 µM protein solution was measured (Fig 24A). The differences in free 
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calcium levels for statherin and PRP1 were within the margin of error in both 
experiments and therefore are not significant. The results for free calcium and 
free phosphate after pre-incubation with intermediate protein concentrations did 
not always follow the expected trend, where greater protein concentration leads 
to greater protection.   
 
Table 9: Comparison of the results of the calcium and phosphate assays.   
 Free Calcium (% decrease) Free Phosphate (% decrease) 
Histatin 1 29 19.4 
Statherin 4.4 6.8 
PRP1 2.1 0.2 
* The values indicate the percent difference between the supernatant from 
unprotected HA after incubation with lactic acid and the supernatant from HA pre-
incubated with the most concentrated protein solution in each experiment and 
subsequent incubation with lactic acid. 
 
 
Several factors could explain the demineralization results. One possibility 
is that the protein to HA ratio was insufficient to adequately protect the HA from 
dissolution. However, the data presented in Table 8 suggest that a sufficient 
amount of protein was present, when the protein concentration increased, the 
percentage of protein bound to HA decreased. It appears that the proteins 
adsorb to HA with insufficient affinity (coverage) to protect against 
demineralization following acid exposure. Another possible explanation for the 
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lack of protection of HA by protein pre-incubation is that the protein could have 
been removed during the washing step. The interaction of the proteins with HA is 
reversible, and washing with water, a polar solvent, may have broken the 
electrostatic bonds between the proteins and HA, especially when coupled with 
the mechanical shearing that occurred when the solution was vortexed.  
  To understand the interaction of the negatively charged salivary proteins 
with hydroxyapatite, it is important to consider the physical properties of the HA 
with respect to protein binding in some more detail. Hay (Hay, 1973) compared 
the interaction of human PS proteins with synthetic HA and dental enamel 
powder. Essentially no differences in binding affinity were observed. It should be 
noted that greater amounts of dental enamel powder were required to obtain 
comparable surface areas since synthetic HA powder has a smaller particle size. 
Carbonate constitutes up to 2.25% of the dry weight of dental enamel and its 
presence causes HA crystals to be smaller and more spherical therefore 
approximating ceramic hydroxyapatite particles. In general, the surface area of 
HA powder is much greater than that of the available tooth enamel surface in the 
oral cavity. 
The HA used in this study was Macro-Prep Ceramic Hydroxyapatite (CHT) 
Type I (40 µm particle size, surface area ~ 40 m2/g) from Bio-Rad. HA has been 
used since the 1950s as a medium in affinity chromatography for the separation 
of biomolecules. Mineral HA is mined from quarries and until recently its use has 
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been limited by the fragile nature of its crystalline hexagonal rods. CHT is a 
spherical, macroporous form of mineral HA that has been sintered at high 
temperatures to modify it from a crystalline to a ceramic form (Fig. 30). In this 
process, the HA morphology changes from hexagonal rods (Fig. 31) to larger, 
spherical particles. CHT is extremely stable, both chemically and physically and 
has been used in column chromatography to separate proteins. Type I CHT 
exhibits a higher binding capacity for proteins, in particular acidic proteins 
whereas type II CHT is better suited for the separation of nucleic acids (Bio-Rad, 
1996).  Hay’s findings (Hay, 1973) showed no essential difference between 
synthetic HA and dental enamel powder with respect to protein binding. The 
chemical composition of ceramic hydroxyapatite (CHT) is virtually identical to 
synthetic HA. The principal observations made in this study could apply to the in 
vivo adsorption process of salivary proteins to tooth enamel.   
 Salivary proteins which exhibit a high affinity for HA are known as “pellicle 
precursor proteins.” Significant modifications and proteolytic processing of 
proteins including statherin and histatin often occurs before or after their 
incorporation into the pellicle structure and the life span of full-length histatins in 
the in vivo whole saliva environment is very short (Helmerhorst et al., 2006). In 
spite of their relatively weak affinity for HA, PRPs are larger in size and are 
present at higher concentrations than histatin 1 and statherin so therefore play a 
critical role in pellicle formation. It should not be assumed that proteins with a 
high affinity for HA in vitro play a significant role in the in the in vivo AEP. The 
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salivary proteins which are the focus of this study, like individual musicians in an 
orchestra, interact with other members and their concerted effort may well 
enhance the protection of tooth enamel.   
Overall, the first aim of this study, to isolate histatins, statherin and acidic 
PRPs from parotid secretion, was successfully achieved. The second aim, to 
establish a spectrophotometric assay for Ca2+ and Phosphate release from 
hydroxyapatite in our laboratory based on pre-existing methods, was realized. 
The third aim was to test the binding of PS proteins to HA and examine the 
subsequent effect on demineralization. N and K values for statherin and histatin 1 
were unequivocally established.  The demineralization protection by salivary 
proteins tested was not very dramatic but was clearly discernable. Future 
experiments could mimic the in vivo conditions under which tooth 
demineralization occurs using weakly acidic buffers and prolonged incubation 
times.    
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Fig. 30: Ceramic Hydroxyapatite (CHT) Beads – 40 µm diameter 
(Pentax. Pentax New Ceramics Site). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 31: HA Crystals in dental enamel (White - Color me for Life). 
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6. APPENDIX 
6.1 SOP: Virtis FM25EL Lyophilizer 
 
Written by: Hank Kells                                     Issue Date: Jan. 19, 2010 
Verified by: Dr. Eva J. Helmerhorst                                    Document nr:  
 
 
Title: Virtis FM25EL Lyophilizer, serial # 217622  
 
 
1. PURPOSE/SCOPE 
 
1.1 To describe the method of using the Virtis FM25 EL Lyophillizer  
 
2. GENERAL 
 
The Virtis Lyophilizer is used to dry aqueous samples.  Samples containing acid or 
organic solvents are not to be put on the lyophilizer. 
 
3. PROCEDURE 
 
3.1) The maximum fill volume of a lyo flask is half of its total volume, ie. the max. fill 
       volume for a 600 ml flask is 300 ml.  Do not overfill the flask.   
3.2) Always use a clean lyo flask and insert a new filter paper disk and a clean O- Ring 
       into the flask cover every time. 
3.3) Shell freeze the flask in the Shell Bath on the Lyophilizer.   
3.3.1) The Bath should be filled with methanol or acetone until the solvent level is 
    about one inch above the rollers.  Make sure the drain hose is plugged before 
    adding solvent to the bath!!!  Make sure the bath is turned on (go to main 
    menu) and allow the bath to cool to at least -70º C before proceeding. 
3.3.2) Insert a polypropylene plug into the flask top.  Place a Stainless Steel 
Bracket Chain above the Bath.   
3.3.3) Lay the flask in the bath at an angle and make sure the chain goes into the 
    groove in the polypropylene plug.  
3.3.4) Adjust the chain length so that the fluid in the flask is close to the top but 
does not come into contact with the flask top.   
3.4) After the sample is frozen solid, remove the flask from the Shell Bath and attach it  
       to one of the ports on the manifold using a stainless steel adapter.  Rotate the white 
       selector knob 180º to put the flask under vacuum.     
3.5) Most samples require at least 24 hours to fully dry.  Samples in which the solution 
        is thicker will take longer to dry. 
3.6) If the flask feels cold, the sample is not dry yet.  The sample is probably dry when 
       the flask is at room temp. and the vacuum reading on the lyophilizer reaches its  
      ultimate low (<20 millitorr).  
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3.7) Release the vacuum in the flask by turning the white selector knob 180º.  Release 
       the vacuum slowly to reduce turbulence inside the flask. 
 
4. Maintenance 
 
4.1) Sign the user’s list and enter the number of flasks and the total volume being 
       lyophilized. 
4.2) To shut down the Lyophilizer: 
4.2.1) Release the system vacuum by opening one of the valves on the manifold 
    (turn the white selector knob 180º).  Immediately press “Auto” on the control 
    panel, this turns off the compressors and the vacuum pump. 
4.2.2) Shut down the lyophilizer if it is not going to be used over a long weekend 
or intersession. 
4.2.3) To restart: Make sure all the valves on the manifold are closed and press  
    “Auto”.  Wait for about 30 min. (until the vacuum is <100 millitorr) before  
    adding samples. 
4.3) Follow the maintenance log.  The vacuum pump oil must be changed monthly.   
 
4.4) Changing the vacuum pump oil: 
4.4.1) Shut down the lyophilizer (see 4.2). 
4.4.2)  Get an 8 mm Allen Wrench from the drawer opposite the lyophilizer.   
4.4.3) Open one of the fill ports on the front of the vacuum pump. 
4.4.4) Attach a length of clear plastic tubing to the drain port on the vacuum 
pump and place the other end of the tubing into a container.   
4.4.5) Open the drain valve and drain all of the oil out of the vacuum pump.  
Elevate the motor end of the pump to ensure all of the oil has been drained. 
4.4.6) Close the drain valve. 
4.4.7) Add fresh oil to the vacuum pump with a funnel.  Use “Elite Z” Synthetic 
    Hydrocarbon Oil from Eastern Scientific.  Add oil until the level is ¾ of the way 
    to the top of the sight glass. 
4.4.8) replace the plug in the fill port using the 8 mm Allen Wrench. 
4.4.9) dispose of the used oil as hazardous waste.   
 
4.5 Defrosting the condenser: 
4.5.1) Shut down the lyophilizer (see 4.2) 
4.5.2) If a fast defrost is desired, press “DEFR” (Quick Defrost). This melts the 
outside of the ice cylinder in about one hour.  The ice can then be pulled out 
of the condenser by hand.  If a fast defrost is not necessary, the ice in the 
condenser will melt overnight. 
4.5.3) Open the condenser door and place a plastic bucket or pan on the floor in 
front of the lyophilizer.  Place a 500 ml Graduated Cylinder under the 
condenser drain port.  Insert the drain hose and connector into the drain port.  
Place the other end of the drain hose into the bucket. 
4.5.4) After the ice has melted, remove any remaining ice from the condenser 
and wipethe condenser chamber dry with paper towels. Wait a few 
minutes before removing the drain hose to make sure all the water has 
drained out. 
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4.5.5) Replace the condenser gasket, if necessary, and close the condenser 
door. 
4.5.6) Restart the lyophilizer (see 4.2 c) 
 
4.6) Alarms  
4.6.1) Alarm conditions include: Power Outage, Condenser over Temperature,  
    Vacuum Exceeded and Vacuum Pump Maintenance.  The most common one  
    is for Vacuum Pump Maintenance.   
4.6.2) The Alarm set point for Vacuum Pump Maintenance is set for 1000 hours. 
    This means that the alarm will sound after the system has been running for 
    1000 hours to prompt the user to change the oil in the vacuum pump. The 
    vacuum pump oil should be changed on a monthly basis so this alarm is 
    superfluous.   
4.6.3) To silence the alarm press MENU on the control panel. 
4.6.4) Access the alarm screen by pressing MENU, scroll to “Alarms” and press  
    MENU again.  Any alarm currently active will be indicated within the alarm 
    screen by a solid box in front of the active alarm.  To clear an alarm use the  
    arrow buttons to scroll to the desired alarm and press the MENU button. 
4.6.5) For more information, see the Operator’s Manual.   
 
5.  Manual Stoppering Assembly 
5.1) Release the vacuum in the lyophilizer by turning one of the white selector 
knobs in a quickseal valve 180º.  Turn off the lyophilizer by pressing “AUTO”.  
Wait a few minutes and turn on the refrigeration by pressing “COND”.  This will 
keep the condenser cold for faster vacuum pulldown.  Remove the Stainless 
Steel Drum Manifold from the top of the lyophilizer (pull it off vertically) and put it 
aside.     
5.2) Pull the black manifold connector gasket up so that it extends about ½” 
above the top of the lyophilizer (to ensure vacuum seal) and place the manifold 
adapter plate on it.  The hole in the center of the adapter plate should line up with 
the hole in the top of the lyophilizer.   
5.3) Place two aluminum racks on the bottom shelf of the stoppering assembly to 
serve as spacers.  All of the vials to be stoppered should be placed on the top 
shelf.  No more than 40 (the number of spaces in one Whatman Vial File) 2 ml 
vials should be lyophilized per run. 
5.4) The sample containing vials should be placed in a Whatman Vial File and 
left in the -80º C. freezer overnight.  Freeze the vials without stoppers.   
5.5) Pre-cool the stoppering assembly and the stoppers by placing them in the 
cold room for at least one hour before loading.  Sample melting is greatly 
reduced when the vials are loaded at 4º C rather than room temp.   
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5.6) When ready, quickly bring the Whatman Vial File from the -80º freezer into 
the cold room.  Remove the frozen vials from the Vial File, partially insert a 
rubber stopper into the top of each vial and place each vial on the top shelf of the 
stoppering assembly.  The stoppers should be partially inserted so that water 
vapor can escape from the sample vial.  The vials should be evenly distributed 
on the top shelf of the stoppering assembly.    
5.7) When all of the vials are loaded gently and carefully pick up the stoppering 
assembly and take it to the lyophilizer (ask someone to hold the doors for you).  
Place the stoppering assembly on the adapter plate so that the three feet of the 
stoppering assembly are each in one of the three depressions on the adapter 
plate.  Carefully place the acrylic manifold over the stoppering assembly and 
make sure the gasket on the bottom of the manifold is seated in the groove in the 
adapter plate.  Insert the stoppering crossbar and plug into the hole in the top of 
the acrylic manifold making sure that the grooves mesh with the T at the top of 
the stoppering assembly.   
5.8) As soon as possible turn on the “VAC” switch to start the vacuum pump.  
The sooner the vacuum is started, the less chance of sample melting.  Make sure 
that the vacuum level begins to decrease (check the display on the front panel of 
the lyophilizer) and that there are no obvious vacuum leaks.   Check again in 15-
20 minutes to make sure that the vacuum level has dropped below 100 milltorr.   
5.9) The samples should be dry after 24 hours.  Connect one end of a length of 
Tygon Tubing to the nitrogen tank and the other end to the 3/8” port on the T 
connector.  Take one Quickseal Valve from the Stainless Steel Manifold and use 
it to plug one end of the T connector.  Attach the other end of the T connector to 
one of the ports on the acrylic manifold.   
5.10) Nitrogen Backfill:  1) Turn off “VAC” switch, 2) Open the valve on the 
nitrogen tank and set the regulator at 10 psi. (you should hear the gas flowing), 
3) Open the Quickseal Valve on the Acrylic Manifold by turning the white selector 
knob 180º, 4) After one minute, close the quickseal valve and stop the backfill.  
Ideally the lyophilizer should remain under a slight vacuum but it is ok to proceed 
even if the vacuum is completely released.   
5.11) Stoppering: Turn the crossbar clockwise until the top plate of the stoppering 
assembly makes contact with the stoppers.  Then turn the crossbar slowly until 
the stoppers are fully seated in the vials.  Do not overtighten or the vials can be 
crushed.   
5.12) After the vials are stoppered, turn the crossbar counterclockwise to raise 
the top shelf.  It may be necessary to separate the top two shelves manually.  
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Remove the stoppered vials from the shelf.  Put them into a Wheaton Vial File 
and bring them to the lab.   
5.13) Obtain the Aluminum Seals and the Seal Crimping Tool.  Place an 
aluminum seal over the stopper and use the crimping tool to attach it to the vial.  
Crimp-seal all of the vials and place them in a Wheaton Vial File.  Label the Vial 
File.  Place the Vial File in the -20 Freezer and/or give to Eva for long-term 
storage.   
Consumable items (order from Fisher Scientific): 
2 ml Thin Wall Serum Vial, Part # 06-406-37, (144/pk) 
13 mm Split Rubber Stopper, Part # 06-447E, (1000/pk)  
13 mm Aluminum Seals, Part # 06-406-14A, (1000/pk)  
 
 
 
 
6.2 SOP: PRP Isolation by Anion-exchange Chromatography 
 
Written by: Hank Kells                                     Issue Date: Jan. 22, 2010 
Verified by: Dr. Eva J. Helmerhorst                                    Document nr:  
 
 
Title: PRP Isolation by Anion-exchange Chromatography 
 
 
1. PURPOSE/SCOPE 
 
1.2 ) To describe the procedure for the isolation of acidic Proline-rich Proteins (aPRPs) 
from human parotid secretion. 
 
2. GENERAL 
The acidic PRP family contains various isoforms including PIF-slow, Db-slow and Pa 
(encoded by the PRH1 gene) and PRP1 and PRP2 (encoded by the PRH2 gene). 
Individuals can be homozygous or heterozygous for PRH1 and PRH2. PRH1/PRH1 can 
yield 3x3=9 possible phenotypes, PRH1/PRH2 can yield 3x2=6 phenotypes, and 
PRH2/PRH2 can yield 2x2=4 phenotypes. Thus in total there are 9+6+4=19 different 
PRP phenotypes. Therefore, for isolating the complete set of PRPs it is important to 
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include several parotid saliva donors (Allele frequencies have been described in the 
literature, Hay et al., J. Dent. Res. 73(11): 1717-1726, 1994).  
PRP1 and PRP2 undergo partial post-translational degradation within the salivary gland, 
yielding PRP3 and PRP4, respectively, and PIF-slow and Db-slow are partially degraded 
into PIF-fast and Db-fast. Pa is the only PRP isoform that contains a cysteine residue 
and forms a dimer (Oppenheim et al., Ann N Y Acad Sci. 098:22-50, 2007). All PRP 
isoforms can be separated by sequential anion-exchange chromatography (DEAE 
followed by MONO Q) and visualized by Ornstein-Davis PAGE and staining with Amido 
Black. Once purity of the isolated PRP isoforms is confirmed, proteins are lyophilized 
and stored for further studies. 
 
3. APPLICABLE DOCUMENTS  
 
3.1) SOP – “Large scale isolation and purification of individual histatins and statherin 
from parotid secretions using zinc chloride precipitation”. 
3.2) SOP – “Virtis FM25EL Lyophilizer” 
3.3) SOP – “Pharmacia FPLC” 
3.4) SOP – “AKTA FPLC” 
3.5) SOP – “Ornstein Davis Gel” 
 
4. PROCEDURE 
 
4.1) Parotid Saliva (PS) is delivered to the Lab (about 300 ml per week).   
 4.1.1) PS is subjected to zinc precipitation to deplete the secretion from 
    histatins and statherins, as described in SOP “large scale isolation and 
    purification of histatins and statherin from parotid secretions using zinc 
    chloride precipitation”.   
 4.1.2) Obtain the supernatant by centrifugation for 20 minutes at 20,000 RPM 
               (27,000 x g)in the Sorvall centrifuge (SS-34 rotor). 
4.2) Dialyze SN using MWCO=1000d membrane (Spectrum Labs, Rancho 
       Dominquez, CA), for 3X4hrs. 
4.3) Transfer SN to lyo flasks and lyophilize (see 3.2). 
4.4) Transfer dry sample to the square bottle in Freezer #4 labeled “Zn- 
        precipitated HPS, contains no histatins”. 
4.5) Weigh out 500 mg (or 1000 mg) of Zn precipitated HPS from the square 
       bottle.   
4.5.1) dissolve in 50 ml (or 100 ml) Buffer A. 
4.5.2) Centrifuge 20 min. at 20,000 rpm.  Use the SS34 Rotor on the Sorvall 
    Centrifuge 
 4.5.3) Remove SN by pipet and discard the pellet. 
4.5.4) Split SN into equal (25ml) aliquots.  Transfer aliquots to 50ml Falcon 
    Tubes with labels ( 250mg HPS for DEAE). 
4.6) Run one aliquot at a time on DEAE Column (old FPLC).   
4.6.1) Use Buffer A as the mobile phase.   
4.6.2) Use the “sephvm” method.  Manually change the name of the run to 
    include the next number in the sequence. 
4.6.3) Set fraction collector to 25 min.  The flow rate = 1 ml/min.  
4.6.4) Let Buffer A flow through the column (manual) until all traces are stable 
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    before starting.  The 214nm UV trace should be about 0.1 AU. 
4.7) DEAE VOID Peak  
4.7.1) Combine the eluent from the tubes containing the DEAE Void Peak in a 
    600 ml lyo flask and lyophilize. 
4.7.2)  Dissolve the dry sample in water and transfer to a 50ml Falcon Tube in 
     Freezer #4 labeled “VOID”.  Keep Void 1 and Void 2 Peaks separate.   
4.7.3) When the VOID Tube is full, run the sample (≤50 ml) through the G-25  
    Column to desalt (old FPLC). 
4.7.4) To switch from DEAE to G-25 Column: 
 Before changing from DEAE to G-25, let buffer A flow through the 
DEAE Column until the conductivity drops below 10 mS. 
 Switch inlet and outlet lines. 
 Place both buffer lines (A&B) into the water container and fill 
container with water. 
 Do pump wash three times to flush lines (turn injection valve to 
waste and start wash).  After three washes turn injection valve to 
load and inject sample. 
 Change method to G25.  The next run number in the sequence 
appears when the run is started. 
 Change fraction size to 5 min.  The flow rate is 5 ml/min (25 ml 
fraction size). 
4.7.5) Transfer the first peak (from G-25) containing the void proteins to a lyo 
    flask and lyophilize.  The second peak contains the salt. 
4.7.6) Transfer the lyophilized Void sample to the box labeled “DEAE Void 
    Peaks” in Freezer #4.  When the Tube is full, give it to Eva. 
4.8) DEAE Peak (contains the acidic, proline rich proteins). 
 4.8.1) Transfer DEAE Peak to a lyo flask and lyophilize.   
4.8.2) Dissolve dry sample in water and transfer to 50ml Falcon Tube in 
    Freezer #4 labeled “DEAE”.  This tube must be kept frozen. Dissolved 
    proteins degrade quickly. 
4.8.3) When the tube is full, run the sample through the G-25 Column (see  
    instructions above).   
4.8.4) Transfer the first peak from the G-25 column (contains the acidic PRP 
    Proteins) to a lyo flask and lyophilize. 
4.8.5) Transfer the dry sample to the square bottle labeled “DEAE for MONO 
    Q Column” in Freezer #4. 
4.9) AKTA FPLC 
4.9.1) Weigh out 50 mg dry “DEAE for MONO Q Column” protein and dissolve 
     in 5 ml Buffer A. 
4.9.2) Filter the solution using a syringe filter (wet the filter with Buffer A first) 
    and inject on the MONO Q Column. 
4.9.3) Refer to the FPLC AKTA SOP. 
4.9.4) Transfer Peaks 1-8, X,Y,Z, etc. to different lyo flasks and lyophilize. 
4.9.5) Dissolve the salty samples in water (separately) and transfer to the 
    corresponding Falcon Tubes in Freezer #4.   
4.9.6) When a tube is full (or nearly full), run the sample through the G-25 
   Column to remove the salt and lyophilize. 
4.9.7) When the sample is light and fluffy, transfer it to the corresponding tube 
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    on the rack labeled “For Davis Gel” in Freezer #4. 
4.10) Davis Gel 
4.10.1) Follow SOP “Ornstein David Gel” to confirm the purity and identity of 
    the proteins  in the different MONO Q Peaks. 
4.11) Final Product 
4.11.1) Once the samples are confirmed to be pure, check their concentration 
    using the Cary 50 UV-Vis at 215nm.  Add 10µl of sample to 990µl of  
    water in a quartz cuvette.  Obtain the OD.  The actual concentration of  
    the protein in solution is 5X the OD (mg/ml).  The concentration should 
    be at least 1.0 mg/ml.  If the concentration is <1.0mg/ml, lyophilize the 
    sample and make it more concentrated.   
4.11.2) Label 2ml Autosampler vials.  The label should indicate the protein, the 
    amount of protein and the date. Aliquot the samples into the vials.  Do 
    not exceed 1.0 ml per vial. 
4.11.3) For each vial insert one cotton plug into a black cap and tighten the cap 
    on the vial.  Make sure that the liquid sample does not come into 
    contact with the cotton plug. 
4.11.4) Place the vials in a plastic box and put the box in the -80º C freezer for 
   16 h (O/N). 
4.11.5) Prepare a 600ml Lyo Flask.  Separate the vials into groups of 8-10 vials 
    and place a rubber band around each group of vials.  Quickly transfer 
    the frozen vials to the flask and put it on the lyophilizer. 
4.11.6) The samples should remain on the lyophilizer for at least 24 hours.  
   After the samples are dry, remove the cotton plugs and insert Teflon  
   discs into each cap (red side up).  Give the vials to Eva for storage in the  
   locked -20º C freezer.    
 
5. Equipment 
 
5.1) Virtis FM25EL Lyophilizer, serial # 217622. 
5.2) Pharmacia FPLC with DEAE and G-25 Columns. 
5.3) AKTA FPLC with MONO Q Column 
5.4) Sorvall RC-6+ Centrifuge and SS-34 Rotor 
  
6. Buffers for DEAE and MONO Q Columns  
 
6.1) Stock Solutions 
6.1.1) 1M TrisHCl pH=8 (2 liters) 
1) Dissolve 242.28 g Tris Base (MW=121.14 g/mol) in 800ml ultrapure 
water in a 1000ml beaker with a magnetic stirrer. 
 2) Transfer the solution to a 2 liter graduated cylinder. 
 3) Use the pH meter to determine the pH of the solution. 
4) Fill the cylinder to the 1800 ml mark with water and allow the pH to 
stabilize. 
5) add 1:1 diluted HCl dropwise until the pH stabilizes at 8.0. than add 
water tol 2 liter line. 
6) Transfer the solution to a labeled 2 liter container 
 6.1.2) 2M NaCl (2 liters)  
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1) Dissolve 233.76 g NaCl (MW=58.44 g/mol) in 1 liter of ultrapure water 
in a 1000 ml beaker with a magnetic stirrer. 
2) Transfer the solution to a 2 liter graduated cylinder. 
3) Fill the cylinder to the 2 liter line with water. 
4) Transfer the solution to a labeled 2 liter container. 
6.2) Buffers 
 6.2.1) Buffer A (50mM Tris/HCl and 50 mM NaCl) 
1)  Add 1800 ml ultrapure water to a 2 liter graduated cylinder.   
2) Add 100 ml of 1M TrisHCl pH=8 stock solution and 50 ml of 2M NaCl 
stock solution to the cylinder.   
3) Fill to the 2 liter line with ultrapure water and filter.   
4) Transfer solution to a properly labeled bottle.   
6.2.2) Buffer B (50mM Tris/HCl and 1M NaCl) 
1) Add 800 ml ultrapure water to a 2 liter graduated cylinder. 
2) Add 100 ml 1M TrisHCl and 1 liter 2M NaCl to the cylinder.    
3) Fill to the 2 liter line with ultrapure water and filter.   
4) Transfer solution to a properly labeled bottle 
 
7. “Buffers” for Gel Filtration Columns 
 
The objective here is to desalt saliva samples.  For this application, pure water is used 
as the running “buffer” in gel filtration chromatography. 
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